<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">95980</article-id><article-id pub-id-type="doi">10.7554/eLife.95980</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Tribbles1 is host protective during in vivo mycobacterial infection</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-272638"><name><surname>Hammond</surname><given-names>Ffion R</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272639"><name><surname>Lewis</surname><given-names>Amy</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1156-3592</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-351917"><name><surname>Pollara</surname><given-names>Gabriele</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149953"><name><surname>Tomlinson</surname><given-names>Gillian S</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4342-3161</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-52395"><name><surname>Noursadeghi</surname><given-names>Mahdad</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4774-0853</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-81455"><name><surname>Kiss-Toth</surname><given-names>Endre</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4406-4017</contrib-id><email>e.kiss-toth@sheffield.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-56333"><name><surname>Elks</surname><given-names>Philip M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1683-0749</contrib-id><email>p.elks@sheffield.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05krs5044</institution-id><institution>The Bateson Centre, School of Medicine and Population Health, Faculty of Health, University of Sheffield</institution></institution-wrap><addr-line><named-content content-type="city">Sheffield</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jx3x895</institution-id><institution>Division of Infection &amp; Immunity, University College London</institution></institution-wrap><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Rothlin</surname><given-names>Carla V</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03v76x132</institution-id><institution>Yale University</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Rothlin</surname><given-names>Carla V</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03v76x132</institution-id><institution>Yale University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>18</day><month>06</month><year>2024</year></pub-date><volume>13</volume><elocation-id>e95980</elocation-id><history><date date-type="received" iso-8601-date="2024-01-10"><day>10</day><month>01</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2024-05-28"><day>28</day><month>05</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2023-08-26"><day>26</day><month>08</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.08.25.553505"/></event></pub-history><permissions><copyright-statement>© 2024, Hammond et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Hammond et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-95980-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-95980-figures-v1.pdf"/><abstract><p>Tuberculosis is a major global health problem and is one of the top 10 causes of death worldwide. There is a pressing need for new treatments that circumvent emerging antibiotic resistance. <italic>Mycobacterium tuberculosis</italic> parasitises macrophages, reprogramming them to establish a niche in which to proliferate, therefore macrophage manipulation is a potential host-directed therapy if druggable molecular targets could be identified. The pseudokinase Tribbles1 (Trib1) regulates multiple innate immune processes and inflammatory profiles making it a potential drug target in infections. Trib1 controls macrophage function, cytokine production, and macrophage polarisation. Despite wide-ranging effects on leukocyte biology, data exploring the roles of Tribbles in infection in vivo are limited. Here, we identify that human Tribbles1 is expressed in monocytes and is upregulated at the transcript level after stimulation with mycobacterial antigen. To investigate the mechanistic roles of Tribbles in the host response to mycobacteria in vivo, we used a zebrafish <italic>Mycobacterium marinum</italic> (Mm) infection tuberculosis model. Zebrafish Tribbles family members were characterised and shown to have substantial mRNA and protein sequence homology to their human orthologues. <italic>trib1</italic> overexpression was host-protective against Mm infection, reducing burden by approximately 50%. Conversely, <italic>trib1</italic> knockdown/knockout exhibited increased infection. Mechanistically, <italic>trib1</italic> overexpression significantly increased the levels of proinflammatory factors <italic>il-1β</italic> and nitric oxide. The host-protective effect of <italic>trib1</italic> was found to be dependent on the E3 ubiquitin kinase Cop1. These findings highlight the importance of Trib1 and Cop1 as immune regulators during infection in vivo and suggest that enhancing macrophage TRIB1 levels may provide a tractable therapeutic intervention to improve bacterial infection outcomes in tuberculosis.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>tuberculosis</kwd><kwd>tribbles</kwd><kwd>zebrafish</kwd><kwd>macrophage</kwd><kwd>neutrophil</kwd><kwd>innate immunity</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Zebrafish</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id award-id-type="doi">10.35802/105570</award-id><principal-award-recipient><name><surname>Elks</surname><given-names>Philip M</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id award-id-type="doi">10.35802/101766</award-id><principal-award-recipient><name><surname>Pollara</surname><given-names>Gabriele</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id award-id-type="doi">10.35802/207511</award-id><principal-award-recipient><name><surname>Noursadeghi</surname><given-names>Mahdad</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100009187</institution-id><institution>Medical Research Foundation</institution></institution-wrap></funding-source><award-id>MR_N007727_1</award-id><principal-award-recipient><name><surname>Tomlinson</surname><given-names>Gillian S</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000691</institution-id><institution>Academy of Medical Sciences</institution></institution-wrap></funding-source><award-id>SGL021\1045</award-id><principal-award-recipient><name><surname>Pollara</surname><given-names>Gabriele</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001320</institution-id><institution>Wolfson Foundation</institution></institution-wrap></funding-source><award-id>WLR\R1\170024</award-id><principal-award-recipient><name><surname>Elks</surname><given-names>Philip M</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication. For the purpose of Open Access, the authors have applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The pseudokinase <italic>Tribbles1</italic> is expressed in human monocytes after mycobacterial challenge and can be manipulated to be host protective against mycobacterial infection, due to control of innate immune cell function, in a zebrafish tuberculosis model.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>With the rise of antimicrobial resistance (AMR), bacterial infections are a major threat to global public health. Tuberculosis, caused by the human pathogen <italic>Mycobacterium tuberculosis</italic>, is a case in point, with 1.6 million deaths worldwide (<xref ref-type="bibr" rid="bib79">WHO, 2022</xref>), many of which are resistant to first- and second-line antibiotic treatments (<xref ref-type="bibr" rid="bib2">Allué-Guardia et al., 2021</xref>; <xref ref-type="bibr" rid="bib24">Hameed et al., 2018</xref>; <xref ref-type="bibr" rid="bib50">Migliori et al., 2013</xref>). To successfully combat AMR there is a pressing and urgent need for alternative treatment strategies to failing antimicrobials. One such approach is offered by the development of host-derived therapies (HDTs), which target systems in the host rather than the pathogen, circumventing AMR (<xref ref-type="bibr" rid="bib36">Kaufmann et al., 2018</xref>; <xref ref-type="bibr" rid="bib37">Kilinç et al., 2021</xref>).</p><p>One primary immune defence against <italic>Mycobacterium tuberculosis</italic> (<italic>Mtb</italic>) is macrophages. Macrophages have a spectrum of phenotypes ranging from proinflammatory to anti-inflammatory, determined in a process known as macrophage polarisation. <italic>Mtb</italic> is expert at manipulation of macrophage polarisation to its advantage (<xref ref-type="bibr" rid="bib1">Ahmad et al., 2022</xref>) and can inhibit the polarisation of proinflammatory macrophages, subverting killing mechanisms to promote intracellular survival of the bacteria and subsequent granuloma formation (<xref ref-type="bibr" rid="bib23">Hackett et al., 2020</xref>). Reprogramming macrophages to better kill <italic>Mtb</italic> is a potential HDT strategy that may be particularly effective against intracellular pathogens (<xref ref-type="bibr" rid="bib69">Sheedy and Divangahi, 2021</xref>).</p><p>Tribbles genes encode for a family of pseudokinases (TRIB1, TRIB2, and TRIB3; <xref ref-type="bibr" rid="bib39">Kiss-Toth et al., 2004</xref>), involved in the regulation of core cellular processes, ranging from cell cycle to glucose metabolism (<xref ref-type="bibr" rid="bib22">Grosshans and Wieschaus, 2000</xref>; <xref ref-type="bibr" rid="bib48">Mata et al., 2000</xref>; <xref ref-type="bibr" rid="bib68">Seher and Leptin, 2000</xref>). The TRIB1 isoform has been strongly associated with macrophage roles in inflammation and innate immunity (<xref ref-type="bibr" rid="bib33">Johnston et al., 2015</xref>; <xref ref-type="bibr" rid="bib52">Niespolo et al., 2020</xref>). TRIB1 regulates multiple important macrophage regulatory factors, especially controlling the proinflammatory response, such as tumour necrosis factor alpha (TNF-α), interleukin-1beta (IL-1β), and nitric oxide (NO) (<xref ref-type="bibr" rid="bib4">Arndt et al., 2018</xref>; <xref ref-type="bibr" rid="bib45">Liu et al., 2013</xref>). <italic>Trib1<sup>−/</sup></italic><sup>−</sup> mice have decreased expression levels of inflammation-related genes such as <italic>IL-6</italic>, <italic>IL-1b</italic>, and <italic>Nos2</italic> (encodes for inducible nitric oxide synthase, iNOS), and murine <italic>Trib1<sup>−/</sup></italic><sup>−</sup> bone marrow-derived macrophages have defective inflammatory, phagocytic, migratory, and NO responses in vitro (<xref ref-type="bibr" rid="bib4">Arndt et al., 2018</xref>; <xref ref-type="bibr" rid="bib45">Liu et al., 2013</xref>).</p><p>TRIB1 influences inflammatory and immune processes via multiple mechanisms. The best described is via recruitment and binding of the E3 ubiquitin ligase constitutive photomorphogenic 1 (COP1). The TRIB1 protein possesses two functional binding sites in its C-terminal, one for COP1 and the second for mitogen-activated protein kinase kinase (MEK) binding. TRIB1 can act as a protein scaffold, binding a substrate to its pseudokinase domain, as well as binding in the functional C terminus to create a regulatory complex. Binding of TRIB1 to the E3 ubiquitin ligase COP1 causes a conformational change, enhancing COP1 binding and bringing COP1 into proximity with the substrate allowing ubiquitination and subsequent degradation (<xref ref-type="bibr" rid="bib32">Jamieson et al., 2018</xref>; <xref ref-type="bibr" rid="bib41">Kung and Jura, 2019</xref>; <xref ref-type="bibr" rid="bib51">Murphy et al., 2015</xref>; <xref ref-type="bibr" rid="bib85">Zahid et al., 2022</xref>). The TRIB1/COP1 complex is responsible for the regulation of multiple targets such as transcription factors, including the tumour suppressor CCAAT/enhancer-binding protein (C/EBPα), which regulates macrophage migration and TNF-α production (<xref ref-type="bibr" rid="bib45">Liu et al., 2013</xref>; <xref ref-type="bibr" rid="bib83">Yoshida et al., 2013</xref>).</p><p>While TRIB1 has been shown to regulate several inflammatory and innate immune functions in vitro, its role in infection is much less characterised, especially in an in vivo setting. <italic>TRIB1</italic> is a predicted target of microRNA–gene interactions that differentiate active and latent TB patients (<xref ref-type="bibr" rid="bib80">Wu et al., 2014</xref>) and is an overabundant transcript in highly proinflammatory tuberculosis-immune reconstitution inflammatory syndrome patients (<xref ref-type="bibr" rid="bib42">Lai et al., 2015</xref>). However, despite these reported potential links between Tribbles and TB, interrogation of <italic>TRIB</italic> isoform transcripts in human mycobacterial datasets had not been performed.</p><p>Over the last two decades, the zebrafish has proved a powerful model for understanding host–pathogen interactions, due to its high-fecundity, transparency of larvae and availability of transgenic reporter lines. A human disease-relevant and tractable infection model is the zebrafish model of tuberculosis, utilising the injection of the natural fish pathogen <italic>Mycobacterium marinum</italic> (Mm), a close genetic relative of <italic>Mtb</italic> (<xref ref-type="bibr" rid="bib16">Davis et al., 2002</xref>; <xref ref-type="bibr" rid="bib74">van der Sar et al., 2009</xref>). This model has shed light on numerous immune pathways involved in host defence, for example hypoxia-inducible factor (HIF) signalling (<xref ref-type="bibr" rid="bib19">Elks et al., 2013</xref>; <xref ref-type="bibr" rid="bib54">Ogryzko et al., 2019</xref>; <xref ref-type="bibr" rid="bib65">Schild et al., 2020</xref>).</p><p>Here, we show that Tribbles1 is expressed in human primary monocytes and its expression is increased at the site of a human in vivo mycobacterial antigen challenge, indicative of a role in TB responses. To substantiate the importance of <italic>TRIB1</italic> in TB pathogenesis, we report a new, protective role for <italic>trib1</italic> in infection defence using an in vivo zebrafish <italic>Mycobacterium marinum</italic> (Mm) infection model. Overexpression of <italic>trib1</italic> significantly reduced Mm burden and increased production of the proinflammatory cytokine <italic>il1b</italic> and NO. The antimicrobial effect of <italic>trib1</italic> overexpression was found to be dependent on <italic>cop1</italic>. Our findings uncover a role for <italic>trib1</italic> in mycobacterial infection defence in vivo, highlighting Trib1 as a potential therapeutic target for manipulation to improve bacterial infection outcomes.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title><italic>TRIB1</italic> is expressed in human monocytes and is upregulated after in vivo mycobacterial antigen stimulation</title><p>To explore whether Tribble pseudokinase expression is modulated by mycobacterial antigen exposure in humans, we initially focused on CD14<sup>+</sup> monocytes stimulated in vitro with <italic>Mtb</italic> protein derivative (PPD). This revealed that mycobacterial antigen exposure induced the expression of TRIB1 isoform transcripts but not TRIB2, which had the lowest baseline expression, nor TRIB3, observations consistent across monocytes from either active or latent TB individuals (<xref ref-type="fig" rid="fig1">Figure 1A–C</xref>). To determine whether Tribbles play a role in human responses in vivo, we turned to the transcriptomic profiles of biopsies from the site of a tuberculin skin test (TST), a routine clinical investigation repurposed into a mycobacterial antigen challenge model (<xref ref-type="bibr" rid="bib7">Bell et al., 2016</xref>). This revealed baseline expression of TRIB1 in control saline injected tissue samples (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Exposure to tuberculin-induced robust induction of TRIB1 expression in TST reactions for both active and latent TB individuals (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). A more modest increase was seen for TRIB2 (<xref ref-type="fig" rid="fig1">Figure 1E</xref>) but not for TRIB3 (<xref ref-type="fig" rid="fig1">Figure 1F</xref>; <xref ref-type="bibr" rid="bib59">Pollara et al., 2021</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Expression of <italic>TRIB1</italic> in human monocytes and tissues is elevated after mycobacterial antigen stimulation.</title><p>(<bold>A–C</bold>) Expression of <italic>TRIB1</italic>, <italic>TRIB2</italic>, and <italic>TRIB3</italic> transcripts in human CD14<sup>+</sup> monocytes in patients with active or latent TB before and after 4 hr of <italic>Mtb</italic> protein derivative (PPD) stimulation in vitro. Each paired data point represents one individual, with active or latent TB (<italic>n</italic> = 9 and <italic>n</italic> = 7, respectively). Statistical significance determined by paired Wilcoxon tests. p values shown are: *p &lt; 0.05 and **p &lt; 0.01. (<bold>D–F</bold>) Expression of <italic>TRIB1</italic>, <italic>TRIB2</italic>, and <italic>TRIB3</italic> within in saline injected human skin and from biopsies of the site of a tuberculin skin test (TST) in patients with active or latent TB. Each point represents one individual with bars for each group representing mean gene expression. <italic>n</italic> = 48 and 191 individuals with active or latent TB, respectively. Statistical significance determined via Kruskal–Wallis with multiple comparisons. p values shown are: ***p &lt; 0.001 and ****p &lt; 0.0001.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Numerical data for the graph of <xref ref-type="fig" rid="fig1">Figure 1A</xref>, left panel.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-95980-fig1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Numerical data for the graph of <xref ref-type="fig" rid="fig1">Figure 1A</xref>, right panel.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-95980-fig1-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata3"><label>Figure 1—source data 3.</label><caption><title>Numerical data for the graph of <xref ref-type="fig" rid="fig1">Figure 1B</xref>, left panel.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-95980-fig1-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata4"><label>Figure 1—source data 4.</label><caption><title>Numerical data for the graph of <xref ref-type="fig" rid="fig1">Figure 1B</xref>, right panel.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-95980-fig1-data4-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata5"><label>Figure 1—source data 5.</label><caption><title>Numerical data for the graph of <xref ref-type="fig" rid="fig1">Figure 1C</xref>, left panel.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-95980-fig1-data5-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata6"><label>Figure 1—source data 6.</label><caption><title>Numerical data for the graph of <xref ref-type="fig" rid="fig1">Figure 1C</xref>, right panel.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-95980-fig1-data6-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata7"><label>Figure 1—source data 7.</label><caption><title>Numerical data for the graph of <xref ref-type="fig" rid="fig1">Figure 1D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-95980-fig1-data7-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata8"><label>Figure 1—source data 8.</label><caption><title>Numerical data for the graph of <xref ref-type="fig" rid="fig1">Figure 1E</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-95980-fig1-data8-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata9"><label>Figure 1—source data 9.</label><caption><title>Numerical data for the graph of <xref ref-type="fig" rid="fig1">Figure 1F</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-95980-fig1-data9-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95980-fig1-v1.tif"/></fig><p>Together these data reveal that TRIB1, and to a lesser extent TRIB2, expression is increased in response to both in vitro and in vivo mycobacterial antigen exposure in humans, independent of clinical TB disease grouping. We interpret these data as signifying a potential functional role for these pseudokinase in regulation of mycobacterial infections in vivo, and indicating the need for a tractable in vivo model of mycobacterial infection to study this further.</p></sec><sec id="s2-2"><title>Zebrafish Tribbles isoforms share homology with their human and mouse counterparts and are expressed in immune cell populations</title><p>To explore the functional role in vivo for Tribbles in the control of mycobacterial infections in vivo, we developed a zebrafish model of <italic>M. marinum</italic> infection and tools to manipulate <italic>tribbles</italic> expression.</p><p>Zebrafish have a single orthologue of each mammalian tribbles isoforms, with <italic>tribbles1</italic> (ENSDARG00000110963/previously ENSDARG00000076142), <italic>tribbles2</italic> (ENSDARG00000068179), and <italic>tribbles3</italic> (ENSDARG00000016200) genes. The exon organisation of Tribbles genes is conserved between human and zebrafish <italic>trib</italic> isoforms. Zebrafish <italic>trib1</italic> has three exons like murine <italic>Trib1</italic> and human <italic>TRIB1</italic> (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Human <italic>TRIB2</italic> and mouse <italic>Trib2</italic> also share this exon structure but are larger than the TRIB1 isoforms (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Zebrafish <italic>trib2</italic> is smaller than human <italic>TRIB2</italic> and mouse <italic>Trib2</italic> at 18.84 kb and only possesses two coding exons (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Human <italic>TRIB3</italic>, mouse <italic>Trib3</italic>, and zebrafish <italic>trib3</italic> share a similar exon organisation with a small non-coding first exon, followed by three coding exons (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Human <italic>TRIB</italic> 1, 2, and 3 are found on chromosomes 8, 2, and 20, respectively, while zebrafish <italic>trib</italic> 1, 2, and 3 are found on chromosomes 19, 20, and 21, respectively. Recently described human-specific variable number tandem repeats in the TRIB3 promotor region (<xref ref-type="bibr" rid="bib56">Örd et al., 2020</xref>) were not identified in 50 kb of the zebrafish promotor region (sequence interrogated was TTg/aCATCA), suggesting potential differences in transcriptional/enhancer regulation, although these even differ between primates and have yet to be fully defined in other mammalian systems (<xref ref-type="bibr" rid="bib56">Örd et al., 2020</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Zebrafish Tribbles share homology with their human and mice counterparts.</title><p>(<bold>A</bold>) The gene organisation of human (orange) TRIB1, mouse (blue) Trib1, and zebrafish (red). Exon maps produced from Ensembl database. Chromosome number location (chr) and transcript sizes in kilobases (kb) are shown. (<bold>B</bold>) Comparison of the three catalytic domains of Tribbles; the pseudokinase catalytic loop and mitogen-activated protein kinase kinase (MEK)/constitutive photomorphogenic 1 (COP1) bind sites, reveals high homology between species. (<bold>C</bold>) NCBI BLAST Global align revealed a high amino acid (AA) homology between zebrafish (zf) and human Tribbles protein sequences. Values described are positives/identities. (<bold>D</bold>) Protein sizes of the first and largest protein-coding transcript of each gene are depicted in the number of AA, values obtained from Ensembl and Uniprot databases. (<bold>E–G</bold>) Protein overlays of predicted structures (AlphaFold DB) of zebrafish (coloured) and human (black) sequences.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>ChimeraX (CXS) file for <xref ref-type="fig" rid="fig2">Figure 2E</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-95980-fig2-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>ChimeraX (CXS) file for <xref ref-type="fig" rid="fig2">Figure 2F</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-95980-fig2-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig2sdata3"><label>Figure 2—source data 3.</label><caption><title>ChimeraX (CXS) file for <xref ref-type="fig" rid="fig2">Figure 2G</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-95980-fig2-data3-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95980-fig2-v1.tif"/></fig><p>Homology between Tribbles isoforms across species is not only observed at the genetic level, but also at the protein level (<xref ref-type="bibr" rid="bib26">Hegedus et al., 2006</xref>). Tribbles have three key protein domains: an N terminal PEST domain, a pseudokinase domain, and a functional C terminal (<xref ref-type="bibr" rid="bib27">Hegedus et al., 2007</xref>). The pseudokinase contains a substrate-binding site within its catalytic loop, and the functional C terminus contains two binding sites for either MEK or COP enzymes (<xref ref-type="bibr" rid="bib61">Qi et al., 2006</xref>; <xref ref-type="bibr" rid="bib82">Yokoyama et al., 2010</xref>). These three binding sites were compared across human, mice, and zebrafish using the NCBI BLAST Global align online tool (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). The pseudokinase catalytic loops in all three Tribbles family proteins (TRIB1–3), are found in human, mouse, and zebrafish. In the case of TRIB1 and TRIB2, there is no variation in the amino acid sequence of the pseudokinase catalytic loop across the three species (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). The pseudokinase catalytic loop of both mouse TRIB3 and zebrafish Trib3 differs slightly from human TRIB3 with two amino acids that are different in mouse TRIB3 and one amino acid difference is observed in zebrafish Trib3. The amino acid sequences of human and zebrafish Tribbles were compared using the NCBI global align tool. Zebrafish Trib1 had the highest percentage identity when compared with human TRIB1 (52%), but also shared sequence homology with human TRIB2 with the highest identities match (66%) (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Zebrafish Trib2 shared the highest percentage identity with human TRIB2 (47% and 54%, respectively). Zebrafish Trib3 had high identity matches for both human TRIB2 and TRIB3 (68% and 64%, respectively) (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). The overall size of Tribbles proteins remains consistent between human and mouse isoforms, with both human and mice TRIB1 sized at 372 amino acids (aa), human and mouse TRIB2 sized at 343aa. Mouse TRIB3 is 4aa shorter than human TRIB3 (354aa compared to 358aa). The zebrafish Tribbles isoforms are generally smaller proteins compared to the human and mouse Tribbles, with zebrafish Trib1 23aa smaller (at 349aa), Trib2 136aa smaller (at 207aa), and Trib3 10aa (at 348aa) compared to the human TRIB isoforms (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Predicted Alphafold models of zebrafish sequences of Trib1 and Trib3 overlayed with human protein predications demonstrate gross fold and alpha helix similarities (<xref ref-type="fig" rid="fig2">Figure 2E, G</xref>). The Trib2 protein overlay was less well conserved, reflective of the smaller amino acid sequence of zebrafish Trib2 compared to human (<xref ref-type="fig" rid="fig2">Figure 2F</xref>).</p><p>To characterise the localisation of <italic>trib</italic> expression across the zebrafish larvae, whole-mount in situ hybridisation probes were developed for each zebrafish <italic>trib</italic> isoform. All <italic>tribbles</italic> isoforms showed highest expression in the brain of the developing zebrafish larvae at 3 dpf compared to sense probe controls (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Expression of <italic>trib</italic> isoforms in immune cells was not detected by whole-mount in situ hybridisation of unchallenged larvae, compared to the expression of the highly expressed immune gene <italic>l-plastin</italic> (<xref ref-type="fig" rid="fig3">Figure 3A–E</xref>). However, this does not negate low, sub-threshold, levels of <italic>tribbles</italic> isoforms in immune cells. <italic>trib</italic> levels in blood cell lineages were assessed using the Zebrafish Blood Atlas web tool (<xref ref-type="bibr" rid="bib5">Athanasiadis et al., 2017</xref>; <ext-link ext-link-type="uri" xlink:href="https://scrnaseq.shinyapps.io/scRNAseq_blood_atlas/">https://scrnaseq.shinyapps.io/scRNAseq_blood_atlas/</ext-link>), based on scRNAseq of adult zebrafish leukocytes. All <italic>trib</italic> isoforms were expressed in subpopulations of neutrophils, monocytes, and thrombocytes. <italic>trib3</italic> was expressed more abundantly and in a larger number of single-cell RNAseq samples than other <italic>trib</italic> isoforms, and was found in macrophages, neutrophils, and thrombocytes (<xref ref-type="fig" rid="fig3">Figure 3F–H</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Expression of zebrafish <italic>tribbles</italic> are located in the brain in larvae and in immune cell subpopulations in adults.</title><p>(<bold>A</bold>) Whole-mount in situ hybridisation of the pan-leukocyte marker <italic>L-plastin</italic> was used as a positive control to stain leukocytes, present predominantly in the caudal hematopoietic tissue (CHT). Scale bar = 200 µm. (<bold>B</bold>) Representative images of antisense and sense (control) whole-mount in situ hybridisation of <italic>tribbles1</italic>. Numbers correspond to number of fish with depictured pattern out of total fish imaged. <italic>N</italic> = 19–20 fish. (<bold>C</bold>) Antisense and sense (control) whole-mount in situ hybridisation of <italic>tribbles2</italic>. <italic>N</italic> = 17–22 fish. (<bold>D</bold>) Antisense and sense (control) whole-mount in situ hybridisation of <italic>tribbles3</italic>. <italic>N</italic> = 17–20 fish. (<bold>E</bold>) Magnified dorsal views (×8 magnification) showing distinct expression of each <italic>trib</italic> isoform in the brain (representative images from each group shown). Scale bar = 200 µm. (<bold>F–H</bold>) Gene expression of adult zebrafish leukocytes determined using the Zebrafish Blood Atlas (<xref ref-type="bibr" rid="bib5">Athanasiadis et al., 2017</xref>). Each point represents a separate scRNAseq sample (cell); replicates performed across multiple zebrafish wildtype and transgenic strains. Each arm of schematic indicates a separate blood cell population (labelled). Deeper colour indicates higher expression (log10 scale bars described for each gene).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95980-fig3-v1.tif"/></fig><p>In summary, zebrafish, mouse, and human Tribbles share sequence similarity and have similar gene organisation and conserved catalytic binding sites, making zebrafish a viable model to explore a physiological role for human Tribbles in mycobacterial infections. Zebrafish express <italic>trib</italic> isoforms in immune cell subpopulations in resting conditions, suggestive of roles in regulating innate immunity.</p></sec><sec id="s2-3"><title>Overexpression of <italic>trib1</italic> is host protective in a zebrafish mycobacteria infection model</title><p>To better understand how Tribbles can influence innate immunity and infection, genetic tools were generated to manipulate expression of zebrafish <italic>trib</italic> isoforms. Overexpression of zebrafish <italic>tribbles</italic> isoforms was achieved by injection of RNA at the one-cell stage. Injection of either <italic>trib1</italic>, <italic>trib2</italic>, or <italic>trib3</italic> RNA did not grossly affect larval development, with embryos developing with no obvious adverse effects (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A, B</xref>). To determine outcomes in infection, a zebrafish <italic>Mycobacterium marinum</italic> (<italic>Mm</italic>) larval model was used, in which <italic><underline>trib</underline></italic> RNAs were injected at the one-cell stage, leading to ubiquitous overexpression. Overexpression of <italic>trib1</italic> significantly decreased bacterial burden of <italic>Mm</italic> by approximately 50% (p &lt; 0.001 compared to the vehicle control, phenol red PR; <xref ref-type="fig" rid="fig4">Figure 4A, B</xref>). Dominant active <italic>hif-1α</italic> (DA1, an RNA shown to significantly reduce <italic>Mm</italic> burden by ~50% <xref ref-type="bibr" rid="bib19">Elks et al., 2013</xref>) was used as a positive RNA control with dominant negative <italic>hif-1α</italic> (DN1, an RNA shown to have no significant effect on <italic>M. marinum</italic> burden) used as a negative RNA control (<xref ref-type="bibr" rid="bib19">Elks et al., 2013</xref>). Overexpression of <italic>trib2</italic> also significantly reduced bacterial burden compared to the PR control, but not to the same extent as the positive DA <italic>hif-1α</italic> control nor <italic>trib1</italic> overexpression (<xref ref-type="fig" rid="fig4">Figure 4A, B</xref>). In contrast, overexpression of <italic>trib3</italic> had no significant effect on the levels of bacterial burden compared to the vehicle PR control (<xref ref-type="fig" rid="fig4">Figure 4A, B</xref>). Together, these data demonstrate that overexpression of <italic>trib1</italic> has the strongest host-protective effect compared to overexpression of other <italic>trib</italic> isoforms, reducing <italic>M. marinum</italic> burden by approximately 50%.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title><italic>trib1</italic> overexpression is host protective against <italic>Mm</italic> infection.</title><p>(<bold>A</bold>) Stereo-fluorescence micrographs of <italic>Mm</italic> mCherry infected 4 dpi larvae after injection at the single-cell stage with dominant active <italic>hif-1α</italic> (DA1), dominant negative <italic>hif-1α</italic> (DN1), <italic>trib1, trib2</italic>, <italic>trib3</italic> RNAs and phenol red (PR) as a negative vehicle control. DA1 and DN1 are RNA controls with DA1 having previously been shown to reduce infection levels (<xref ref-type="bibr" rid="bib19">Elks et al., 2013</xref>). Scale bar = 200 µm. (<bold>B</bold>) Bacterial burden of larvae shown in (<bold>A</bold>). Data shown are mean ± standard error of the mean (SEM), <italic>n</italic> = 76–77 in <italic>trib1</italic>, <italic>n</italic> = 86–89 in <italic>trib2</italic>, and <italic>n</italic> = 43–95 in <italic>trib3</italic>, accumulated from three independent experiments for each <italic>trib</italic> gene. Statistical significance determined via one-way analysis of variance (ANOVA) with Bonferroni’s multiple comparisons. p values shown are: **p &lt; 0.01 and ***p &lt; 0.001. (<bold>C</bold>) Stereo-fluorescence micrographs of Mm mCherry infected 4 dpi larvae after injection with <italic>tyrosinase</italic> (control), <italic>trib1</italic> and <italic>trib3</italic> CRISPR guides (CRISPants). Scale bar = 200 µm. (<bold>D</bold>) Bacterial burden of larvae shown in (<bold>C</bold>). Data shown are mean ± SEM, <italic>n</italic> = 87–90 fish accumulated from three independent experiments. Statistical significance determined via one-way ANOVA with Bonferroni’s multiple comparisons. p values shown are: ***p &lt; 0.001. (<bold>E</bold>) Bacterial burden of <italic>trib1<sup>−/−</sup></italic> stable knockout larvae compared to wildtype (<italic>trib1<sup>+/+</sup></italic>) siblings. Data shown are mean ± SEM, <italic>n</italic> = 82–114 fish accumulated from four independent experiments. Statistical significance determined via an unpaired <italic>t</italic>-test. p values shown are: *p &lt; 0.05.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Numerical data for the graph of <xref ref-type="fig" rid="fig4">Figure 4B</xref> <italic>trib1</italic>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-95980-fig4-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Numerical data for the graph of <xref ref-type="fig" rid="fig4">Figure 4B</xref> <italic>trib2</italic>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-95980-fig4-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata3"><label>Figure 4—source data 3.</label><caption><title>Numerical data for the graph of <xref ref-type="fig" rid="fig4">Figure 4B</xref> <italic>trib2</italic>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-95980-fig4-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata4"><label>Figure 4—source data 4.</label><caption><title>Numerical data for the graph of <xref ref-type="fig" rid="fig4">Figure 4D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-95980-fig4-data4-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata5"><label>Figure 4—source data 5.</label><caption><title>Numerical data for the graph of <xref ref-type="fig" rid="fig4">Figure 4E</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-95980-fig4-data5-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95980-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title><italic>tribbles</italic> RNA overexpression caused no observable developmental defects.</title><p>(<bold>A</bold>) cDNA sequences of zebrafish <italic>trib</italic> isoforms (<italic>trib1</italic>, <italic>trib2</italic>, and <italic>trib3</italic>) were cloned into the expression plasmid pCS2+. (<bold>B</bold>) mRNA of <italic>trib</italic> isoforms (100 ng/μl) was synthesised from pCS2+ plasmids and 1 nl was injected into one-cell stage zebrafish embryos, which resulted in healthy development. Larvae imaged at 2 dpf using stereoscope at ×4 magnification (head images at ×8 magnification). Scale bars = 100 µM.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95980-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>CRISPR guide RNAs against <italic>trib1</italic> and <italic>trib3</italic> efficiently disrupt a restriction digest site.</title><p>(<bold>A</bold>) Electrophoresis gel of larvae injected with <italic>trib1</italic> guide RNA with a SacII restriction digest. The undigested DNA band, obtained using the polymerase chain reaction (PCR), is 177 bp and the successfully digested band is 132 bp. Two uninjected fish were used as controls without (U) and with (D) digestion. Four <italic>tyrosinase</italic> (<italic>tyr</italic>) control guide injected larvae had conserved SacII sites while 6/6 <italic>trib1</italic> larvae did not digest with SacII indicating a genomic disruption at the CRISPR PAM site. First and last lanes of gel images contain Low Molecular Weight DNA Ladder (New England Biolabs, N3233) for reference. (<bold>B</bold>) Electrophoresis gel of larvae injected with <italic>trib3</italic> guide RNA with a MwoI restriction digest. The undigested PCR band is 186 bp and the successfully digested band is 103 bp. Two uninjected fish were used as controls without (U) and with (D) digestion. Four <italic>tyrosinase</italic> (<italic>tyr</italic>) guide injected larvae had conserved MwoI sites while 5/6 <italic>trib3</italic> larvae did not digest with MwoI indicating a genomic disruption at the CRISPR PAM site. First and last lanes of gel images contain NEB Low Molecular Weight ladder for reference.</p><p><supplementary-material id="fig4s2sdata1"><label>Figure 4—figure supplement 2—source data 1.</label><caption><title>Raw unedited gel image of <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-95980-fig4-figsupp2-data1-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig4s2sdata2"><label>Figure 4—figure supplement 2—source data 2.</label><caption><title>PDF containing <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A</xref> and the original gel image with highlighted bands and samples labels.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-95980-fig4-figsupp2-data2-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig4s2sdata3"><label>Figure 4—figure supplement 2—source data 3.</label><caption><title>Raw unedited gel image of <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2B</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-95980-fig4-figsupp2-data3-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig4s2sdata4"><label>Figure 4—figure supplement 2—source data 4.</label><caption><title>PDF containing <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2B</xref> and the original gel image with highlighted bands and samples labels.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-95980-fig4-figsupp2-data4-v1.pdf"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95980-fig4-figsupp2-v1.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>Generation of a <italic>tribbles1</italic> stable mutant line.</title><p>(<bold>A</bold>) Schematic of zebrafish <italic>trib1</italic> gene exons, with arrowhead showing location of CRISPR guide RNA PAM site in exon 1. (<bold>B</bold>) Electrophoresis gel of larvae injected with <italic>trib1</italic> guide RNA with a SacII restriction digest. The undigested PCR band is 177 bp and the successfully digested band is 132 bp. Two uninjected fish were used as controls without (U) and with (D) digestion. Four cas9 only injected larvae had conserved SacII sites while 6/6 <italic>trib1</italic> larvae did not digest with SacII indicating a genomic disruption at the CRISPR PAM site. LMW = NEB Low Molecular Weight ladder for reference. (<bold>C</bold>) Sequencing trace of a <italic>trib1<sup>−/−</sup></italic> mutant versus a wildtype sibling, demonstrating a 14-bp deletion (loss of <named-content content-type="sequence">AGCAGATGTCCGCG</named-content>). (<bold>D</bold>) Schematic showing predicted truncated protein (Δ94aa) caused by <italic>trib1<sup>−/−</sup></italic> mutation compared to the wildtype protein. (<bold>E</bold>) Stereo-fluorescence micrographs of Mm mCherry infected 4 dpi <italic>trib1<sup>−/−</sup></italic> mutant and wildtype (<italic>trib1<sup>+/+</sup></italic>) sibling larvae. Scale bar = 200 µM. (<bold>F</bold>) Sudan Black staining of neutrophils in 3 dpf <italic>trib1<sup>−/−</sup></italic> mutant and wildtype (<italic>trib1<sup>+/+</sup></italic>) sibling larvae. Scale bar = 200 µM. (<bold>G</bold>) Number of Sudan Black-positive neutrophils in the tail of 3 dpf <italic>trib1<sup>−/−</sup></italic> mutant and wildtype (<italic>trib1<sup>+/+</sup></italic>) sibling larvae. Data shown are mean ± standard error of the mean (SEM), <italic>n</italic> = 16–17 fish accumulated from two independent experiments. Statistical significance (no significance, ns) determined via an unpaired <italic>t</italic>-test.</p><p><supplementary-material id="fig4s3sdata1"><label>Figure 4—figure supplement 3—source data 1.</label><caption><title>Raw unedited gel image of <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3B</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-95980-fig4-figsupp3-data1-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig4s3sdata2"><label>Figure 4—figure supplement 3—source data 2.</label><caption><title>PDF containing <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3B</xref> and the original gel image with highlighted bands and samples labels.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-95980-fig4-figsupp3-data2-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig4s3sdata3"><label>Figure 4—figure supplement 3—source data 3.</label><caption><title>Numerical data for the graph of <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3G</xref>.</title></caption><media mimetype="application" mime-subtype="octet-stream" xlink:href="elife-95980-fig4-figsupp3-data3-v1.csv"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95980-fig4-figsupp3-v1.tif"/></fig></fig-group><p><italic>trib</italic> knockdown/knockout tools were developed using CRISPR–Cas9 technology. Guide RNAs for each <italic>trib</italic> isoform were designed targeting the first coding exon of each <italic>trib</italic> gene and were injected into one-cell stage embryos, with <italic>tyrosinase</italic> (a control CRISPant which has negligible effects on innate immunity; <xref ref-type="bibr" rid="bib31">Isles et al., 2019</xref>) CRISPant as a negative control. CRISPant efficiency was tested using PCR and restriction enzyme digest, with successful CRISPants disrupting the restriction site. Efficient guide RNAs were developed for both <italic>trib1</italic> and <italic>trib3</italic> (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A, B</xref>), however guide RNAs for <italic>trib2</italic> did not cause efficient knockdown. <italic>Trib1</italic> CRISPants had a higher burden of Mm compared to <italic>tyrosinase</italic> and <italic>trib3</italic> CRISPants (<xref ref-type="fig" rid="fig4">Figure 4C, D</xref>). To confirm the <italic>trib1</italic> knockdown phenotype, a stable CRISPR–Cas9 mutant for <italic>trib1</italic> was developed. Genotyping of F1 <italic>trib1</italic> CRISPR–Cas9 mutants revealed a 14-bp deletion (<named-content content-type="sequence">AGCAGATGTCCGCG</named-content>) at the start of exon 1 (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3A–C</xref>). This 14 bp deletion is predicted to create a truncated protein that is 94aa in length compared to the full-length 349aa wildtype protein, lacking the catalytic loop in the pseudokinase domain (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3D</xref>) assuming no nonsense-mediated decay. Heterozygous <italic>trib1<sup>+/−</sup></italic> were in-crossed and larvae were infected with Mm in the caudal vein at 1 dpi, imaged at 4 dpi and subsequently genotyped. At 4 dpi Mm infected <italic>trib1<sup>−/−</sup></italic> mutants had significantly higher levels of bacterial burden compared to <italic>trib1<sup>+/+</sup></italic> wildtype siblings (<xref ref-type="fig" rid="fig4">Figure 4E</xref>, <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3E</xref>).</p></sec><sec id="s2-4"><title><italic>trib1</italic> manipulation does not affect total leukocyte numbers in larvae</title><p>TRIB1 has previously been shown to affect immune cell differentiation, with full-body <italic>Trib1</italic>-deficient mice possessing a greater number of neutrophils and a reduced number of anti-inflammatory macrophages compared to wildtype (<xref ref-type="bibr" rid="bib64">Satoh et al., 2013</xref>). Zebrafish <italic>trib</italic> isoforms 1 and 3 were manipulated in neutrophil and macrophage transgenic reporter lines <italic>Tg(mpx:GFP)i114</italic> and <italic>Tg(mpeg:nlsclover)sh436</italic> and whole-body fluorescent cell counts were performed at 2 dpf to assess whether <italic>trib</italic> manipulation influenced zebrafish leukocyte number. Neither <italic>trib1/trib3</italic> overexpression nor <italic>trib1/trib3</italic> CRISPant knockdown grossly affected neutrophil or macrophage numbers (<xref ref-type="fig" rid="fig5">Figure 5A–D</xref>). Due to neutrophil numbers being most affected in the <italic>Trib1</italic>-deficient mice, we further investigated at the later timepoint of 3 dpf to determine whether neutrophil differentiation was affected and found that <italic>Tg(mpx:GFP)i114</italic>-positive neutrophil numbers were unchanged with <italic>trib1</italic> overexpression (<xref ref-type="fig" rid="fig5">Figure 5E</xref>) and <italic>trib1</italic> CRISPant knockdown (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). We confirmed these data using a second neutrophil reporter transgenic line <italic>Tg(lyz: nfsB.mCherry)sh260</italic> with <italic>trib1</italic> overexpression (<xref ref-type="fig" rid="fig5">Figure 5G</xref>) and <italic>trib1</italic> CRISPant knockdown (<xref ref-type="fig" rid="fig5">Figure 5H</xref>) showing no differences in numbers at 2 and 3 dpf. These data suggest that the host-protective effect of <italic>trib1</italic> overexpression is not due to an increase in number of innate immune cells.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title><italic>trib</italic> manipulation does not affect leukocyte number in zebrafish larvae.</title><p>(<bold>A</bold>) Example brightfield and fluorescent micrographs of neutrophils (<italic>Tg(mpx:GFP)i114</italic>) in four 2 dpf larvae injected at the one-cell stage with either phenol red (PR), <italic>trib1</italic> RNA overexpression (OE), <italic>trib1</italic> CRISPant, <italic>trib3</italic> RNA overexpression (OE), or <italic>trib3</italic> CRISPant. Scale bars = 200 µM. (<bold>B</bold>) Example brightfield and fluorescent micrographs of macrophages (<italic>Tg(mpeg:nlsclover)sh436</italic>) in four 2 dpf larvae injected at the one-cell stage with either PR, <italic>trib1</italic> RNA overexpression (OE), <italic>trib1</italic> CRISPant, <italic>trib3</italic> RNA overexpression (OE), or <italic>trib3</italic> CRISPant. Scale bars = 200 µM. (<bold>C</bold>) Wholebody neutrophil numbers (<italic>Tg(mpx:GFP)i114</italic>) in 2 dpf larvae injected at the one-cell stage with either PR, <italic>trib1</italic> RNA overexpression (T1 OE), <italic>trib1</italic> CRISPant (T1 cpr), <italic>trib3</italic> RNA overexpression (T3 OE), or <italic>trib3</italic> CRISPant (T3 cpr). Data shown are mean ± standard error of the mean (SEM), <italic>n</italic> = 30 fish per group. (<bold>D</bold>) Wholebody macrophage numbers (<italic>Tg(mpeg:nlsclover)sh436</italic>) in 2 dpf larvae injected at the one-cell stage with either PR, <italic>trib1</italic> RNA overexpression (T1 OE), <italic>trib1</italic> CRISPant (T1 cpr), <italic>trib3</italic> RNA overexpression (T3 OE), or <italic>trib3</italic> CRISPant (T3 cpr). Data shown are mean ± SEM, <italic>n</italic> = 30 fish per group. (<bold>E</bold>) Total tail neutrophil numbers (<italic>Tg(mpx:GFP)i114</italic>) in 3 dpf larvae injected at the one-cell stage with either PR or <italic>trib1</italic> RNA overexpression (T1 OE). Data shown are mean ± SEM, <italic>n</italic> = 30 fish per group. (<bold>F</bold>) Total tail neutrophil numbers (<italic>Tg(mpx:GFP)i114</italic>) in 3 dpf larvae injected at the one-cell stage with either <italic>tyrosinase</italic> control CRISPant (tyr cpr) or <italic>trib1</italic> CRISPant (T1 cpr). Data shown are mean ± SEM, <italic>n</italic> = 30 fish per group. (<bold>G</bold>) Total tail neutrophil numbers (<italic>Tg(lyz: nfsB.mCherry)sh260</italic>) in 2 and 3 dpf larvae injected at the one-cell stage with either PR or <italic>trib1</italic> RNA overexpression (T1 OE). Data shown are mean ± SEM, <italic>n</italic> = 37–42 fish per group. (<bold>H</bold>) Total tail neutrophil numbers (<italic>Tg(lyz: nfsB.mCherry)sh260</italic>) in 2 and 3 dpf larvae injected at the one-cell stage with either <italic>tyrosinase</italic> control CRISPant (tyr cpr) or <italic>trib1</italic> CRISPant (T1 cpr). Data shown are mean ± SEM, <italic>n</italic> = 60 fish per group.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Numerical data for the graph of <xref ref-type="fig" rid="fig5">Figure 5C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-95980-fig5-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Numerical data for the graph of <xref ref-type="fig" rid="fig5">Figure 5D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-95980-fig5-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig5sdata3"><label>Figure 5—source data 3.</label><caption><title>Numerical data for the graph of <xref ref-type="fig" rid="fig5">Figure 5E</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-95980-fig5-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig5sdata4"><label>Figure 5—source data 4.</label><caption><title>Numerical data for the graph of <xref ref-type="fig" rid="fig5">Figure 5F</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-95980-fig5-data4-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig5sdata5"><label>Figure 5—source data 5.</label><caption><title>Numerical data for the graph of <xref ref-type="fig" rid="fig5">Figure 5G</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-95980-fig5-data5-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig5sdata6"><label>Figure 5—source data 6.</label><caption><title>Numerical data for the graph of <xref ref-type="fig" rid="fig5">Figure 5H</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-95980-fig5-data6-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95980-fig5-v1.tif"/></fig></sec><sec id="s2-5"><title><italic>trib1</italic> overexpression increases production of proinflammatory factors</title><p>Zebrafish <italic>trib1</italic> manipulation had a profound effect on host–pathogen interaction, with overexpression reducing Mm bacterial burden and CRISPant knockdown/CRISPR mutant increasing burden. We therefore investigated the roles of <italic>trib1</italic> manipulation on the innate immune system. To investigate whether <italic>trib1</italic> influenced the inflammatory profiles of zebrafish leukocytes, production of the proinflammatory factors, <italic>il-1β</italic> and NO were measured using a combination of transgenic reporter lines and immunostaining. Overexpression of <italic>trib1</italic> increased the levels of <italic>il1β:GFP</italic> (in a <italic>Tg(il-1β:GFP)sh445</italic> reporter line), to similar levels as the positive control DA Hif-1α, compared to PR injected controls (<xref ref-type="fig" rid="fig6">Figure 6A, B</xref>). <italic>trib3</italic> overexpression did not increase levels of <italic>il1β:GFP</italic> and levels were similar to the negative controls DN Hif-1α and PR (<xref ref-type="fig" rid="fig6">Figure 6A, B</xref>). Similarly, <italic>trib1</italic> overexpression increased the levels of anti-nitrotyrosine staining (a proxy for immune cell antimicrobial NO production; <xref ref-type="bibr" rid="bib21">Forlenza et al., 2008</xref>) compared to PR controls, to similar levels as DA Hif-1α (<xref ref-type="bibr" rid="bib20">Elks et al., 2014</xref>; <xref ref-type="bibr" rid="bib19">Elks et al., 2013</xref>; <xref ref-type="fig" rid="fig6">Figure 6C, D</xref>). <italic>trib3</italic> overexpression did not increase levels of proinflammatory nitrotyrosine (<xref ref-type="fig" rid="fig6">Figure 6C, D</xref>).</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title><italic>trib1</italic> overexpression increases production of proinflammatory <italic>il-1β</italic> and nitrotyrosine in the absence of infection.</title><p>(<bold>A</bold>) Fluorescent confocal micrographs of 2 dpf caudal vein region of <italic>TgBAC(il-1β:eGFP)sh445</italic> transgenic larvae. <italic>il-1β:GFP</italic> expression was detected by GFP levels. Larvae were injected at the one-cell stage with dominant negative (DN) or dominant active (DA) Hif-1α or phenol red (PR) controls and <italic>trib1</italic> and <italic>trib3</italic> test RNAs. Scale bars = 25 μm. (<bold>B</bold>) Corrected fluorescence intensity levels of <italic>il-1β:GFP</italic> confocal z-stacks in uninfected larvae at 2 dpf of data shown in (<bold>A</bold>). Dominant active Hif-1α (DA1) controls and <italic>trib1</italic> fish had significantly increased <italic>il-1β:GFP</italic> levels in the absence of Mm bacterial challenge compared to PR and dominant negative Hif-1α (DN1) injected controls and <italic>trib3</italic> RNA injected embryos. Data shown are mean ± standard error of the mean (SEM), <italic>n</italic> = 108 cells from 18 embryos accumulated from 3 independent experiments. Statistical significance was determined using one-way analysis of variance (ANOVA) with Bonferroni’s multiple comparisons post hoc test. p values shown are: ***p &lt; 0.001. (<bold>C</bold>) Fluorescence confocal z-stacks of the caudal vein region of 2 dpf <italic>mpx:GFP</italic> larvae (neutrophils) immune labelled with anti-nitrotyrosine (cyan) in the absence of Mm infection. Larvae were injected at the one-cell stage with dominant negative (DN) or dominant active (DA) Hif-1α or PR controls and <italic>trib1</italic> and <italic>trib3</italic> test RNAs. Scale bars = 25 μm. (<bold>D</bold>) Corrected fluorescence intensity levels of anti-nitrotyrosine antibody confocal z-stacks shown in (<bold>C</bold>). Data shown are mean ± SEM, <italic>n</italic> = 108 cells from 18 embryos accumulated from 3 independent experiments. Statistical significance was determined using one-way ANOVA with Bonferroni’s multiple comparisons post hoc test. p values shown are: ***p &lt; 0.001.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Numerical data for the graph of <xref ref-type="fig" rid="fig6">Figure 6B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-95980-fig6-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title>Numerical data for the graph of <xref ref-type="fig" rid="fig6">Figure 6D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-95980-fig6-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95980-fig6-v1.tif"/></fig></sec><sec id="s2-6"><title><italic>Trib1</italic> overexpression does not activate Hif signalling</title><p>Tribbles regulation has been mechanistically linked to hypoxia and HIF-1α in a variety of cancer cells (<xref ref-type="bibr" rid="bib29">Hong et al., 2019</xref>; <xref ref-type="bibr" rid="bib78">Wennemers et al., 2011</xref>; <xref ref-type="bibr" rid="bib81">Xing et al., 2020</xref>) and in <italic>Drosophila</italic> fat body tissue (<xref ref-type="bibr" rid="bib53">Noguchi et al., 2022</xref>). Due to the host-protective effect of <italic>trib1</italic> overexpression in Mm infection closely mimicking that of DA-Hif1α, a potential mechanistic link between the <italic>hif-1α</italic> and <italic>trib1</italic> pathways was investigated. <italic>trib1</italic> and <italic>trib3</italic> were overexpressed in a Hif-α transgenic reporter line, <italic>Tg(phd3:GFP)i144</italic> (<italic>phd3</italic> is a downstream target of Hif-α signalling) (<xref ref-type="bibr" rid="bib63">Santhakumar et al., 2012</xref>). Neither <italic>trib1</italic> nor <italic>trib3</italic> overexpression activated the <italic>phd3:GFP</italic> line to detectable levels, indicating that <italic>trib1</italic> overexpression is not substantially increasing Hif-1α signalling to mediate <italic>Mm</italic> control (<xref ref-type="fig" rid="fig7">Figure 7A, B</xref>). These data suggest that the protective effects of <italic>trib1</italic> act via a different mechanism than Hif-1α activation.</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title><italic>trib1</italic> and <italic>trib3</italic> overexpression do not induce expression of the Hif reporter <italic>phd3:GFP</italic>.</title><p>(<bold>A</bold>) Stereo-fluorescence micrographs of 2 dpf <italic>phd3:GFP</italic> larvae injected with phenol red (PR), dominant active <italic>hif-1α</italic> (DA1) and dominant negative Hif-1α (DN1) RNA controls alongside <italic>trib1</italic> (T1) and <italic>trib3</italic> (T3) RNA. Scale bars = 200 µM. (<bold>B</bold>) Corrected fluorescence intensity levels of <italic>phd3:GFP</italic> (Hif reporter) larvae shown in (<bold>A</bold>). Data shown are mean ± standard error of the mean (SEM), <italic>n</italic> = 30 embryos accumulated from three independent experiments. Statistical significance determined through one-way analysis of variance (ANOVA) with multiple comparisons. p values shown are: ***p &lt; 0.001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95980-fig7-v1.tif"/></fig></sec><sec id="s2-7"><title>The host-protective effect of <italic>trib1</italic> is dependent on <italic>cop1</italic></title><p>An important binding partner of the TRIB1 protein is the E3 ubiquitin ligase, COP1 (<xref ref-type="bibr" rid="bib32">Jamieson et al., 2018</xref>; <xref ref-type="bibr" rid="bib41">Kung and Jura, 2019</xref>; <xref ref-type="bibr" rid="bib51">Murphy et al., 2015</xref>). To investigate whether the host-protective effects of <italic>trib1</italic> overexpression in <italic>Mm</italic> infection were <italic>cop1</italic>-mediated, a <italic>cop1</italic> CRISPant was generated. The zebrafish <italic>cop1</italic> gene (ENSDARG00000079329) is located on the forward strand of chromosome 2 and has 20 exons, all of which are coding (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1A, B</xref>). It has a single coding transcript, producing a Cop1 protein of 694 amino acids. The zebrafish <italic>cop1</italic> gene shares synteny and conserved sequence with both the human COP1 and murine Cop1 (determined using the ZFIN database <ext-link ext-link-type="uri" xlink:href="https://zfin.org/">https://zfin.org/</ext-link>). Cop1 mutant larvae appeared normal with no gross developmental defect and had no change in wholebody neutrophil number at 2 dpf (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1C</xref>).</p><p>In order to investigate whether the protective effect of <italic>trib1</italic> overexpression is <italic>cop1</italic>-mediated, <italic>trib1</italic> overexpression was combined with <italic>cop1</italic> CRISPants in <italic>Mm</italic> infected larvae. Overexpression of <italic>trib1</italic> significantly reduced bacterial burden compared to PR controls when co-injected with <italic>tyrosinase</italic> guide (<xref ref-type="fig" rid="fig8">Figure 8A, B</xref>). The bacterial burden of <italic>cop1</italic> CRISPants was not significantly different to the tyrosinase control group nor the tyrosinase control with <italic>trib1</italic> overexpression group. When <italic>trib1</italic> was overexpressed in <italic>cop1</italic> CRISPants, there was no significant decrease in burden, with the protective effect of <italic>trib1</italic> lost (<xref ref-type="fig" rid="fig8">Figure 8A, B</xref>) indicating that the protective effect of <italic>trib1</italic> overexpression is dependent on <italic>cop1</italic>.</p><fig-group><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>The host-protective effect of <italic>trib1</italic> overexpression requires <italic>cop1</italic>.</title><p>(<bold>A</bold>) Stereo-fluorescence micrographs of Mm mCherry infected 4 dpi larvae after injection with <italic>trib1</italic> RNA (overexpression, OE) and <italic>cop1</italic> guide RNA (CRISPants, <italic>cpr</italic>) using phenol red (PR, vehicle) and <italic>tyrosinase</italic> (<italic>tyr cpr</italic>, unrelated guide RNA) CRISPants as negative controls. Scale bar = 200 µM. (<bold>B</bold>) Bacterial burden of larvae shown in (<bold>A</bold>). Data shown are mean ± standard error of the mean (SEM), <italic>n</italic> = 71–76 accumulated from three independent experiments. Statistical significance determined via one-way analysis of variance (ANOVA) with Bonferroni’s multiple comparisons. p values shown are: **p &lt; 0.01 and ***p &lt; 0.001. (<bold>C</bold>) Fluorescence confocal z-stacks of the caudal vein region of 2 dpf <italic>mpx:GFP</italic> larvae (neutrophils) immune labelled with anti-nitrotyrosine (cyan) in the absence of Mm infection. Larvae were injected at the one-cell stage with <italic>trib1</italic> RNA (overexpression, OE) and <italic>cop1</italic> guide RNA (CRISPants, cpr) using PR (vehicle) and tyrosinase (unrelated guide RNA) CRISPants as negative controls. Scale bar = 30 μm. (<bold>D</bold>) Corrected fluorescence intensity levels of anti-nitrotyrosine antibody confocal z-stacks shown in (<bold>C</bold>). Data shown are mean ± SEM, <italic>n</italic> = 108 cells from 18 embryos accumulated from three independent experiments. Statistical significance was determined using one-way ANOVA with Bonferroni’s multiple comparisons post hoc test. p values shown are: ****p &lt; 0.0001.</p><p><supplementary-material id="fig8sdata1"><label>Figure 8—source data 1.</label><caption><title>Numerical data for the graph of <xref ref-type="fig" rid="fig8">Figure 8B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-95980-fig8-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig8sdata2"><label>Figure 8—source data 2.</label><caption><title>Numerical data for the graph of <xref ref-type="fig" rid="fig8">Figure 8D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-95980-fig8-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95980-fig8-v1.tif"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 1.</label><caption><title>An efficient CRISPR–Cas9 guide RNA was generated for the zebrafish <italic>cop1</italic> gene.</title><p>(<bold>A</bold>) The zebrafish <italic>cop1</italic> gene (ENSDARG00000079329) has one coding transcript which was used as a basis for CRISPR–Cas9 guide design. Exon map and gene information obtained from Ensembl database. The web tool ChopChop was used to design a <italic>cop1</italic> guide RNA with suitable restriction enzyme bind site (black line). PAM cut site (NGG) denoted with blue line. (<bold>B</bold>) Electrophoresis gel of larvae injected with <italic>cop1</italic> guide RNA (cpr) with a Hyp188I restriction digest. The undigested PCR band is 250 bp and the successfully digested band is 147 bp. Two uninjected fish were used as controls without (U) and with (D) digestion. Four <italic>tyrosinase</italic> (<italic>tyr</italic>) guide injected larvae had conserved SacII sites while 6/6 <italic>cop1</italic> larvae did not digest with Hyp188I indicating a genomic disruption at the CRISPR PAM site. First and last lanes of gel images contain NEB Low Molecular Weight ladder for reference. (<bold>C</bold>) Wholebody <italic>Tg(mpx:GFP)i114</italic> neutrophil numbers in 2 dpf larvae injected at the one-cell stage with either phenol red (PR), <italic>trib1</italic> RNA overexpression (<italic>trib1</italic>), <italic>tyrosinase</italic> CRISPant (<italic>tyr</italic>), <italic>trib1</italic> and <italic>tyrosinase</italic> CRISPant (<italic>tyr + trib1</italic>), <italic>cop1</italic> CRISPant (<italic>cop1</italic>), or <italic>cop1</italic> and <italic>trib1</italic> CRISPant (<italic>cop1 + trib1</italic>). Data shown are mean ± standard error of the mean (SEM), <italic>n</italic> = 15 fish per group.</p><p><supplementary-material id="fig8s1sdata1"><label>Figure 8—figure supplement 1—source data 1.</label><caption><title>Raw unedited gel image of <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1B</xref>.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-95980-fig8-figsupp1-data1-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig8s1sdata2"><label>Figure 8—figure supplement 1—source data 2.</label><caption><title>PDF containing <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1B</xref> and the original gel image with highlighted bands and samples labels.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-95980-fig8-figsupp1-data2-v1.pdf"/></supplementary-material></p><p><supplementary-material id="fig8s1sdata3"><label>Figure 8—figure supplement 1—source data 3.</label><caption><title>Numerical data for the graph of <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1C</xref>.</title></caption><media mimetype="application" mime-subtype="octet-stream" xlink:href="elife-95980-fig8-figsupp1-data3-v1.csv"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-95980-fig8-figsupp1-v1.tif"/></fig></fig-group><p>The effect of <italic>cop1</italic> knockdown on the production of antimicrobial NO production was investigated using the anti-nitrotyrosine antibody. Overexpression of <italic>trib1</italic> significantly increased neutrophil anti-nitrotyrosine fluorescence levels compared to the PR control in the <italic>tyrosinase</italic> controls (<xref ref-type="fig" rid="fig8">Figure 8C, D</xref>). The <italic>cop1</italic> CRISPant group possessed comparable anti-nitrotyrosine levels to both the PR and tyrosinase control groups. <italic>trib1</italic> overexpression in the <italic>cop1</italic> CRISPants did not increase anti-nitrotyrosine levels and instead was comparable with the <italic>cop1</italic> CRISPants alone and both PR and tyrosinase controls (<xref ref-type="fig" rid="fig8">Figure 8C, D</xref>).</p><p>Together these data show that when <italic>cop1</italic> is knocked down the antimicrobial and host-protective effects of <italic>trib1</italic> overexpression are lost, indicating a dependency of the <italic>trib1</italic> effect on <italic>cop1</italic>.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>TRIB1 has previously been shown to be a key regulator of multiple inflammatory factors and immune cell function, influencing pathologies with an inflammatory component including cancer and atherosclerosis (<xref ref-type="bibr" rid="bib33">Johnston et al., 2015</xref>). Innate immunity and production of inflammatory factors are important defence mechanisms against invading pathogens, yet the role of Tribbles in the immune response to infection is poorly understood. Here, we provide evidence that mycobacterial antigen stimulation both in vitro and in vivo induces human TRIB1 and TRIB2 expression independent of TB disease status. We used a zebrafish TB model to show that <italic>trib1</italic> expression has functional roles in the innate immune response to infection in vivo. trib1 is required to control Mm infection, associated with increased production of the antimicrobial factors <italic>il-1β</italic> and NO. We also show a role for <italic>cop1</italic>, a binding partner of TRIB1, which is required for the host-protective effects of <italic>trib1</italic> overexpression. The in vivo tools, developed here to investigate the immune roles of <italic>tribbles</italic> in zebrafish, create new opportunities to further investigate Tribbles1 as a potential therapeutic target, not only in infection, but in a wider range of disease contexts that have an innate immunity component.</p><p>For the first time, we have identified that Tribbles1 is important in the host response to mycobacterial infection, with <italic>TRIB1</italic> being upregulated in human monocytes after mycobacterial antigen challenge and overexpression of <italic>trib1</italic> being host-protective in a zebrafish TB model. TRIB1 is a well-known regulator of innate immune cells and functions in inflammatory settings playing a key role in the regulation of proinflammatory profiles (<xref ref-type="bibr" rid="bib4">Arndt et al., 2018</xref>; <xref ref-type="bibr" rid="bib52">Niespolo et al., 2020</xref>; <xref ref-type="bibr" rid="bib57">Ostertag et al., 2010</xref>). <italic>Trib1<sup>−/</sup></italic><sup>−</sup> mice have a defective inflammatory response, with reduced proinflammatory gene expression (including <italic>Nos2</italic> and <italic>Il-1β</italic> compared to controls) resulting in bone-marrow-derived macrophages (BMDMs) that produce lower NO and have defective phagocytosis (<xref ref-type="bibr" rid="bib4">Arndt et al., 2018</xref>). In zebrafish, <italic>trib1</italic> overexpression increased production of proinflammatory factors, indicating that similar control of NO and Il-1β by TRIB1 is conserved in fish, although NO was primarily observed in neutrophils rather than macrophages matching previous observations in the zebrafish model (<xref ref-type="bibr" rid="bib20">Elks et al., 2014</xref>; <xref ref-type="bibr" rid="bib19">Elks et al., 2013</xref>).</p><p>TRIB1 has been associated with inflammation and immune response, whereas TRIB3 is strongly associated with metabolic function, including the regulation of glucose homeostasis (<xref ref-type="bibr" rid="bib3">Angyal and Kiss-Toth, 2012</xref>; <xref ref-type="bibr" rid="bib60">Prudente et al., 2012</xref>; <xref ref-type="bibr" rid="bib86">Zhang et al., 2013</xref>) which also has regulatory roles in innate immune cells such as macrophages (<xref ref-type="bibr" rid="bib70">Steverson et al., 2016</xref>; <xref ref-type="bibr" rid="bib76">Wang et al., 2012</xref>). There are robust links between glucose metabolism and innate immune responses, such as the glycolytic switch which is closely related to macrophage polarisation (<xref ref-type="bibr" rid="bib87">Zhu et al., 2015</xref>). Immune cell glucose and lipid metabolism have important roles in infection defence. Lipid droplets form in macrophages during <italic>Mtb</italic> infection that are potentially used as source of lipids by <italic>Mtb</italic> to allow for intracellular growth (<xref ref-type="bibr" rid="bib14">Daniel et al., 2011</xref>). However, more recent findings suggest that lipid droplets are formed during the immune activation process after macrophage <italic>Mtb</italic> infection (<xref ref-type="bibr" rid="bib40">Knight et al., 2018</xref>), that can subsequently influence the dynamic response of macrophage host defence (<xref ref-type="bibr" rid="bib49">Menon et al., 2019</xref>). In murine atheroma models, Trib1 increased the lipid accumulation in macrophages leading to the formation of foam cells (<xref ref-type="bibr" rid="bib34">Johnston et al., 2019</xref>). In <italic>Drosophila melanogaster</italic>, <italic>trbl</italic> knockdown increased circulating triglyceride levels (<xref ref-type="bibr" rid="bib15">Das et al., 2014</xref>) and in mice where TRIB3 knockdown in a murine adipose cell line (3T3-L1) increased intracellular triglycerides (<xref ref-type="bibr" rid="bib72">Takahashi et al., 2008</xref>) and targeted deletion of murine TRIB3 resulted in elevated triglyceride levels in the liver (<xref ref-type="bibr" rid="bib55">Örd et al., 2018</xref>). Macrophage lipid metabolism and handling during <italic>Mtb</italic> infection could therefore potentially be influenced by Tribbles.</p><p>It is interesting to note that overexpression or knockdown of <italic>trib</italic> genes did not affect macrophage and neutrophil differentiation in zebrafish larvae. Trib1-deficient mice have been shown to have defects in the differentiation of a number of different immune cells, including an increase in neutrophils due to commitment of the granulocyte precursor lineage to neutrophils at the expense of eosinophils (<xref ref-type="bibr" rid="bib47">Mack et al., 2019</xref>) and a decrease in M2-like tissue-resident macrophages (<xref ref-type="bibr" rid="bib64">Satoh et al., 2013</xref>). The effects of Trib1 deficiency on eosinophil/neutrophil differentiation has been shown to be dependent on C/EBP transcription factors (<xref ref-type="bibr" rid="bib47">Mack et al., 2019</xref>). Similar to mammalian neutrophil differentiation, zebrafish neutrophil differentiation is partially regulated by C/EBP transcription factors including Cebpα (<xref ref-type="bibr" rid="bib12">Dai et al., 2016</xref>; <xref ref-type="bibr" rid="bib84">Yuan et al., 2011</xref>), Cebp1 (the functional homolog of mammalian C/EBPε, <xref ref-type="bibr" rid="bib38">Kim et al., 2016</xref>) and Cebpβ (<xref ref-type="bibr" rid="bib77">Wei et al., 2020</xref>). It was therefore surprising that <italic>trib1</italic> manipulation did not affect neutrophil differentiation in the zebrafish and highlights potential differences between the function of zebrafish <italic>trib1</italic> compared to murine TRIB1. An important C/EBP in zebrafish myelopoiesis is a zebrafish-specific isoform called Cebp1 that is myeloid expressed (<xref ref-type="bibr" rid="bib46">Lyons et al., 2001</xref>). This has a highly conserved carboxy-terminal bZIP domain with mammalian homologues, but the amino-terminal domains are unique. Reduction of Cebp1 did not ablate initial macrophage or granulocyte development in 24 hpf zebrafish larvae (<xref ref-type="bibr" rid="bib46">Lyons et al., 2001</xref>). Recent findings demonstrate that Cebp1 controls eosinophilopoiesis in zebrafish larvae and has important roles in balancing the neutrophil and eosinophil lineages (<xref ref-type="bibr" rid="bib44">Li et al., 2024</xref>), as in mice (<xref ref-type="bibr" rid="bib47">Mack et al., 2019</xref>), however, eosinophils do not emerge until after 5 dpf beyond the stages in our study (<xref ref-type="bibr" rid="bib6">Balla et al., 2010</xref>; <xref ref-type="bibr" rid="bib44">Li et al., 2024</xref>). It remains unclear as to whether M2-like macrophages are affected by <italic>trib1</italic> modulation in zebrafish as they are in mice (<xref ref-type="bibr" rid="bib64">Satoh et al., 2013</xref>), as biomarkers/transgenic tools to investigate the existence of M2-like macrophages in larvae have only recently been developed (<xref ref-type="bibr" rid="bib25">Hammond et al., 2023</xref>), but could be of interest in future studies.</p><p>Many of the reported regulatory functions of TRIB1 in immune cells are dependent on COP1 (<xref ref-type="bibr" rid="bib41">Kung and Jura, 2019</xref>). In our zebrafish Mm model the protective effect of <italic>trib1</italic> overexpression was reduced when <italic>cop1</italic> was depleted, demonstrating a requirement for <italic>cop1</italic> expression to improve the host response to infection. Interestingly, <italic>cop1</italic> CRISPants possess a subtly reduced burden compared to controls without the overexpression of <italic>trib1</italic>, suggesting that <italic>cop1</italic> depletion alone may offer a small level of protection. In cancer cell lines infected with <italic>Mycobacterium bovis</italic> Bacillus Calmette–Guérin (BCG), BCG-induced Sonic Hedgehog signalling increasing COP1 expression, leading to the inhibition of apoptosis in the cell line (<xref ref-type="bibr" rid="bib28">Holla et al., 2014</xref>), indicating there may be a COP1 response to mycobacterial infection. The TRIB1/COP1 complex is responsible for the regulation of multiple targets, including C/EBPs (<xref ref-type="bibr" rid="bib45">Liu et al., 2013</xref>; <xref ref-type="bibr" rid="bib83">Yoshida et al., 2013</xref>). The lack of changes observed in neutrophil and macrophage numbers in <italic>trib1</italic>/<italic>cop1</italic> knockdowns in our zebrafish studies, discussed above, may be suggestive of C/EBP independent mechanisms. There is evidence suggesting that COP1 and C/EBP have distinct binding sites on TRIB1, potentially unlinking their activity in some biological situations and this may be the case in zebrafish haematopoeisis (<xref ref-type="bibr" rid="bib51">Murphy et al., 2015</xref>). There are many other candidate pathways other than C/EBPs that Trib1 and Cop1 interactions can influence that could lead to the host-protective effect observed, with examples including mitogen-activated protein kinases (<xref ref-type="bibr" rid="bib52">Niespolo et al., 2020</xref>), serine threonine kinases (<xref ref-type="bibr" rid="bib17">Durzynska et al., 2017</xref>), JAK/STAT (<xref ref-type="bibr" rid="bib4">Arndt et al., 2018</xref>), and beta-Catenin (<xref ref-type="bibr" rid="bib85">Zahid et al., 2022</xref>), likely context and cell dependent. For example, the neutrophil NO response generated by <italic>trib1</italic> overexpression in zebrafish could be produced through JAK/STAT signalling which, in mice, regulates macrophage NO via TRIB1 control of STAT3 and STAT6 (<xref ref-type="bibr" rid="bib4">Arndt et al., 2018</xref>). The zebrafish will be a useful in vivo model to investigate and dissect these pathways further.</p><p>If proinflammatory signals are initiated early in infection, this can reduce infection burden and improve infection outcomes. An example of this is control of the proinflammatory response by HIF-1α, where early stabilisation and activation of HIF-1α signalling is host beneficial in mycobacterial infection (<xref ref-type="bibr" rid="bib19">Elks et al., 2013</xref>; <xref ref-type="bibr" rid="bib43">Lewis and Elks, 2019</xref>; <xref ref-type="bibr" rid="bib54">Ogryzko et al., 2019</xref>). The host-protective effect of <italic>trib1</italic> overexpression closely mimicked the effects of Hif-1α stabilisation, with an increase in the production of antimicrobial factors NO and <italic>il-1β</italic> and a decrease in <italic>Mm</italic> infection burden (<xref ref-type="bibr" rid="bib19">Elks et al., 2013</xref>; <xref ref-type="bibr" rid="bib54">Ogryzko et al., 2019</xref>). TRIB3 has been associated with HIF-1α in renal cell carcinoma patients with HIF-1α binding to multiple regions in the TRIB3 promoter resulting in upregulation of TRIB3 expression (<xref ref-type="bibr" rid="bib29">Hong et al., 2019</xref>). In lung adenocarcinoma cells, TRIB3 knockdown decreased levels of HIF-1α (<xref ref-type="bibr" rid="bib81">Xing et al., 2020</xref>), indicating a feedback loop between TRIB3 and HIF-1α, where one can regulate the other. In common with TRIB3, a potential link between TRIB2 and HIF-1α has been reported, as depletion of TRIB2 significantly decreased the effect of TNF-α on HIF-1α stability and accumulation in multiple cancer cell lines (<xref ref-type="bibr" rid="bib67">Schoolmeesters et al., 2012</xref>). However, there is no current link identified between TRIB1 and HIF-1α and this was reflected in our findings showing that <italic>trib1</italic> overexpression did not lead to an increase in a well-validated Hif-α reporter line (<xref ref-type="bibr" rid="bib63">Santhakumar et al., 2012</xref>).</p><p>Together our findings show a potential therapeutic application of targeting Trib1 to improve infection outcomes. We demonstrate <italic>il-1b</italic> and NO control by Trib1, suggesting that Trib1 controls multiple immune pathways and that therapeutic Trib1 manipulation may be more effective than targeting individual immune pathways alone. Due to its potential functions in multiple pathways, any targeting of Trib1 must be carefully controlled. For example, overexpression of TRIB1 in chronic mycobacterial infections may be beneficial against infection, but could trigger immunopathology. The concept of host immunomodulation is an emerging therapeutic avenue for infectious disease, especially with the continually increasing problem of AMR in multiple pathogens, and could potentially be used alongside antimicrobial drug treatment. To aid the efficiency of host immunomodulation, and to help avoid off-target effects, specific targeting methods can be used. Polymersomes have been shown to be a promising avenue for drug delivery to immune cells and could be utilised for the delivery of host immunomodulatory compounds and factors (<xref ref-type="bibr" rid="bib13">Dal et al., 2020</xref>). Further research into TRIB1 as a target for host-derived therapies could potentially improve infection outcome of mycobacterial infection via pharmacological targeted delivery methods and transient manipulation through genetic approaches.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Gene (<italic>Danio rerio</italic>)</td><td align="left" valign="bottom"><italic>TgBAC(mpx:EGFP)i114</italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib18">Elks et al., 2011</xref></td><td align="left" valign="bottom">i114Tg<break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:ZFIN_ZDB-ALT-070118-2">ZFIN_ZDB-ALT-070118-2</ext-link></td><td align="left" valign="bottom">Transgenic</td></tr><tr><td align="left" valign="bottom">Gene (<italic>Danio rerio</italic>)</td><td align="left" valign="bottom"><italic>Tg(lyz:nfsβ-mCherry)sh260</italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib11">Buchan et al., 2019</xref></td><td align="left" valign="bottom">sh260Tg RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:ZFIN_ZDB-ALT-190925–14">ZFIN_ ZDB-ALT-190925–14</ext-link></td><td align="left" valign="bottom">Transgenic</td></tr><tr><td align="left" valign="bottom">Gene (<italic>Danio rerio</italic>)</td><td align="left" valign="bottom"><italic>Tg(mpeg:nlsclover)</italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib9">Bernut et al., 2019</xref></td><td align="left" valign="bottom">sh436Tg RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:ZFIN_ZDB-ALT-191219-4">ZFIN_ZDB-ALT-191219-4</ext-link></td><td align="left" valign="bottom">Transgenic</td></tr><tr><td align="left" valign="bottom">Gene (<italic>Danio rerio</italic>)</td><td align="left" valign="bottom"><italic>Tg(mpeg1:mCherryCAAX)</italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib10">Bojarczuk et al., 2016</xref></td><td align="left" valign="bottom">sh378Tg RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:ZFIN_ZDB-ALT-160414–5">ZFIN_ZDB-ALT-160414–5</ext-link></td><td align="left" valign="bottom">Transgenic</td></tr><tr><td align="left" valign="bottom">Gene (<italic>Danio rerio</italic>)</td><td align="left" valign="bottom"><italic>Tg(phd3:GFP)</italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib63">Santhakumar et al., 2012</xref></td><td align="left" valign="bottom">sh144Tg RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:ZFIN_ZDB-ALT-120925-1">ZFIN_ZDB-ALT-120925-1</ext-link></td><td align="left" valign="bottom">Transgenic</td></tr><tr><td align="left" valign="bottom">Gene (<italic>Danio rerio</italic>)</td><td align="left" valign="bottom"><italic>TgBAC(il-1β:GFP)</italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib54">Ogryzko et al., 2019</xref></td><td align="left" valign="bottom">Sh445Tg RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:ZFIN_ZDB-ALT-190307-8">ZFIN_ZDB-ALT-190307-8</ext-link></td><td align="left" valign="bottom">Transgenic</td></tr><tr><td align="left" valign="bottom">Gene (<italic>Danio rerio</italic>)</td><td align="left" valign="bottom"><italic>trib1<sup>sh628/sh628</sup></italic> CRISPR mutant</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">sh628</td><td align="left" valign="bottom">CRISPR mutant</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Danio rerio</italic>)</td><td align="left" valign="bottom"><italic>trib1</italic> CRISPR–Cas9 guide RNA</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"><italic>trib1</italic> CRISPR</td><td align="left" valign="bottom"><named-content content-type="sequence">AGCCCGTGAGCAGATGTCCGCGG</named-content></td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Danio rerio</italic>)</td><td align="left" valign="bottom"><italic>trib3</italic> CRISPR–Cas9 guide RNA</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"><italic>trib3</italic> CRISPR</td><td align="left" valign="bottom"><named-content content-type="sequence">TCAACTCGCTTCAGTCGCAGTGG</named-content></td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Danio rerio</italic>)</td><td align="left" valign="bottom"><italic>cop1</italic> CRISPR–Cas9 guide RNA</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"><italic>cop1</italic> CRISPR</td><td align="left" valign="bottom"><named-content content-type="sequence">CGAGCTGCTCCCGTTCTGAGCGG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>trib1_fw</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom"><named-content content-type="sequence">TACGGGCATTTCACTTTCGG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>trib1_rev</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom"><named-content content-type="sequence">GTGAGGATCCCAGGAGACC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>trib3_fw</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom"><named-content content-type="sequence">ACCTGTTCAATCTTGTTGTCACA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>trib3_rev</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom"><named-content content-type="sequence">GGAAGGAGGCTGACTGAGTC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>cop1_fw</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom"><named-content content-type="sequence">TTCAATTATGTCAAGCACTCGG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>cop1_rev</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom"><named-content content-type="sequence">CAAGGGTCTTTTCCTGCTTAAA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>trib1cloning_fw</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom"><named-content content-type="sequence">TACGGGCATTTCACTTTCGG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>trib1cloning_rev</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom"><named-content content-type="sequence">CAGTCCTTAAACCCGACACG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>trib2cloning_fw</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom"><named-content content-type="sequence">CACCATGAACATACAGAGATCCAG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>trib2cloning_rev</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom"><named-content content-type="sequence">TTGCTACATCACTCAACGCC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>trib3cloning_fw</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom"><named-content content-type="sequence">CAACTAAGTGCGCCTGTAGT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>trib3cloning_rev</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom"><named-content content-type="sequence">TGCCCTTGAACTCTGCATAC</named-content></td></tr><tr><td align="left" valign="bottom">Genetic reagent<break/>(<italic>Danio rerio</italic>)</td><td align="left" valign="bottom"><italic>tyrosinase</italic> CRISPR-Cas9 guide RNA</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib31">Isles et al., 2019</xref></td><td align="left" valign="bottom"><italic>tyr CRISPR</italic></td><td align="left" valign="bottom"><named-content content-type="sequence">GGACTGGAGGACTTCTGGGG</named-content>(AGG)</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mycobacterium marinum</italic>)</td><td align="left" valign="bottom"><italic>Mycobacterium marinum</italic> strain M (ATCC #BAA-535), containing the pSMT3-mCherry vector</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib74">van der Sar et al., 2009</xref></td><td align="left" valign="bottom"><italic>Mycobacterium marinum</italic> strain M ATCC #BAA-535</td><td align="left" valign="bottom">Transgenic</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-nitrotyrosine antibody (rabbit polyclonal)</td><td align="left" valign="bottom">Merck</td><td align="left" valign="bottom">06–284; Merck Millipore</td><td align="left" valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-rabbit Alexa Fluor 633-conjugated secondary antibody (goat polyclonal)</td><td align="left" valign="bottom"/><td align="left" valign="bottom">A-21071; ThermoFisher</td><td align="left" valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">DIG RNA Labeling Kit (SP6/T7)</td><td align="left" valign="bottom">Roche</td><td align="left" valign="bottom">11175025910; Roche, Merck</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">mMessageMachine SP6 Transcription Kit</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">AM1340; Invitrogen</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">QIAquick Gel Extraction Kit</td><td align="left" valign="bottom">QIAGEN</td><td align="left" valign="bottom">28704; QIAGEN</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">Zero Blunt TOPO PCR Cloning Kit</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">K280002; Invitrogen</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">BASiCz</td><td align="left" valign="bottom">Blood atlas of single cells in zebrafish</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.sanger.ac.uk/tool/basicz/">https://www.sanger.ac.uk/tool/basicz/</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ChopChop</td><td align="left" valign="bottom">ChopChop</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://chopchop.cbu.uib.no/">http://chopchop.cbu.uib.no/</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Primer3</td><td align="left" valign="bottom">ELIXIR</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://primer3.ut.ee/">https://primer3.ut.ee/</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">LASX</td><td align="left" valign="bottom">Leica Microsystems</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.leica-microsystems.com/products/microscope-software/p/leica-las-x-ls/downloads/">https://www.leica-microsystems.com/products/microscope-software/p/leica-las-x-ls/downloads/</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">AlphaFold DB</td><td align="left" valign="bottom">Deepmind/EMBL-EBI</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://alphafold.ebi.ac.uk/">https://alphafold.ebi.ac.uk/</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ChimeraX</td><td align="left" valign="bottom">UCSF</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.cgl.ucsf.edu/chimerax/">https://www.cgl.ucsf.edu/chimerax/</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Prism 10</td><td align="left" valign="bottom">Graphpad</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/">https://www.graphpad.com/</ext-link></td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Materials availability statement</title><p>Further information and requests for resources and reagents developed here, including the newly created genetic tools for <italic>tribbles</italic> manipulation, should be directed to and will be fulfilled by the corresponding author Philip Elks (p.elks@sheffield.ac.uk).</p></sec><sec id="s4-2"><title>Human transcriptomic dataset analysis</title><p>Expression of TRIB1 in human CD14<sup>+</sup> monocytes and the site of a TST was derived from publicly available transcriptomic data deposited in EBI ArrayExpress repository (datasets E-MTAB-8162 and E-MTAB-6816, respectively – <ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/biostudies/arrayexpress">https://www.ebi.ac.uk/biostudies/arrayexpress</ext-link>) where the recruitment of patients with active and latent TB was approved by UK National Research Ethics Committees (reference numbers: 14/LO/0505, 16/LO/0776, and 18/LO/0680) and was subject to written informed consent (<xref ref-type="bibr" rid="bib59">Pollara et al., 2021</xref>).</p></sec><sec id="s4-3"><title>Protein structure predictions</title><p>Predicated protein structures were sourced from AlphaFold DB (<xref ref-type="bibr" rid="bib35">Jumper et al., 2021</xref>; <xref ref-type="bibr" rid="bib75">Varadi et al., 2022</xref>). Overlays of predicted protein structures were produced using UCSF ChimeraX, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, USA (<xref ref-type="bibr" rid="bib58">Pettersen et al., 2021</xref>).</p></sec><sec id="s4-4"><title>Zebrafish</title><p>Zebrafish were raised in The Biological Services Aquarium (University of Sheffield, UK) and maintained according to standard protocols (<ext-link ext-link-type="uri" xlink:href="https://zfin.org/">https://zfin.org/</ext-link>) in Home Office approved facilities. All procedures were performed on embryos pre 5.2 dpf which were therefore outside of the Animals (Scientific Procedures) Act, to standards set by the UK Home Office. Emybros/larvae from clutches were randomly allocated into groups pre manipulation. Adult fish were maintained at 28°C with a 14/10 hr light/dark cycle. Nacre zebrafish were used as a wildtype. Transgenic zebrafish lines used in this study were <italic>Tg(mpx:GFP)i114</italic> (<xref ref-type="bibr" rid="bib62">Renshaw et al., 2006</xref>), <italic>TgBAC(il-1β:GFP)sh445</italic> (<xref ref-type="bibr" rid="bib54">Ogryzko et al., 2019</xref>), <italic>Tg(mpeg:nlsclover)sh436</italic> (<xref ref-type="bibr" rid="bib9">Bernut et al., 2019</xref>), <italic>Tg(mpeg1:mCherryCAAX)sh378</italic> (<xref ref-type="bibr" rid="bib10">Bojarczuk et al., 2016</xref>), <italic>Tg(lyz:nfsB.mCherry)sh260</italic> (<xref ref-type="bibr" rid="bib11">Buchan et al., 2019</xref>), and <italic>Tg(phd3:GFP)i144</italic> (<xref ref-type="bibr" rid="bib63">Santhakumar et al., 2012</xref>).</p></sec><sec id="s4-5"><title>CRISPR–Cas9 guide design and CRISPant generation</title><p>Transcript details for <italic>trib1</italic> (current Ensembl entry code is ENSDARG00000110963, but previously coded as ENSDARG00000076142 which is the identifier code used in RNAseq datasets), <italic>trib2</italic> (ENSDARG00000068179), and <italic>trib3</italic> (ENSDARG00000016200) were obtained from Ensembl genome browser (<ext-link ext-link-type="uri" xlink:href="https://www.ensembl.org/">https://www.ensembl.org/</ext-link>). Only one transcript was identified per gene which was used for CRISPR–Cas9 guide design. The web tool ChopChop (<ext-link ext-link-type="uri" xlink:href="https://chopchop.cbu.uib.no">https://chopchop.cbu.uib.no</ext-link>) was used to design guide RNAs and primers (<italic>trib1</italic>: guide RNA: <named-content content-type="sequence">AGCCCGTGAGCAGATGTCCGCGG</named-content>, F primer: <named-content content-type="sequence">TACGGGCATTTCACTTTCGG</named-content>, R primer: <named-content content-type="sequence">GTGAGGATCCCAGGAGACC</named-content>, restriction digest: SacII. <italic>trib3</italic>: guide RNA: <named-content content-type="sequence">TCAACTCGCTTCAGTCGCAGTGG</named-content>, F primer: <named-content content-type="sequence">ACCTGTTCAATCTTGTTGTCACA</named-content> , R primer: <named-content content-type="sequence">GGAAGGAGGCTGACTGAGTC</named-content>, restriction digest: Mwol. <italic>cop1</italic>: guide RNA: <named-content content-type="sequence">CGAGCTGCTCCCGTTCTGAGCGG</named-content>, F primer: <named-content content-type="sequence">TTCAATTATGTCAAGCACTCGG</named-content> , R primer: <named-content content-type="sequence">CAAGGGTCTTTTCCTGCTTAAA</named-content>, restriction digest: Hyp188I).</p><p>To genotype first genomic DNA was extracted from 2 to 4 dpf larvae via incubation at 95°C in 100 µl of 50 mM NaOH for 20 min followed by the addition of 10 µl 1 M Tris–HCl (pH 8). PCR was then performed on genomic DNA with relevant primer pair and enzyme (NEB). Digests were run on a 2% (wt/vol) agarose gel (Sigma, Merck) at 100 V. Samples that were positive for CRISPR mutation were not digested by the restriction enzyme due to destruction of the restriction enzyme recognition site.</p><p>All guide RNAs (Sigma, Merck) were microinjected in the following injection mix: 1 μl 20 mM guide RNA, 1 μl 20 mM Tracr RNA (Sigma, Merck), 1 μl Cas9 (diluted 1:3 in diluent B, NEB), 1 μl water (water was replaced with 100 ng/μl <italic>trib1</italic> RNA for <italic>cop1</italic> experiments). A <italic>tyrosinase</italic> guide RNA (Sigma, Merck) control that has negligible effects on innate immunity was used as a negative CRISPR (<xref ref-type="bibr" rid="bib31">Isles et al., 2019</xref>). Embryos were microinjected with 1 nl guide RNA mix at the single-cell stage to generate F0 CRISPants.</p><p>Generation of trib1<sup>−/−</sup> mutant zebrafish <italic>trib1<sup>−/−</sup></italic> (<italic>trib1<sup>SH628</sup>/trib1<sup>SH628</sup></italic>) mutant embryos were generated by CRISPR–Cas9-mediated mutagenesis targeted around a SacII restriction site in the first exon of <italic>trib1</italic> (using the method described by <xref ref-type="bibr" rid="bib30">Hruscha et al., 2013</xref>) and the <italic>trib1</italic> guide RNA sequence shown in <xref ref-type="table" rid="table1">Table 1</xref> and the Key resources table.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Summary of CRISPR-Cas9 guideRNAs, relevant primers and restriction enzymes used for genotyping.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Gene</th><th align="left" valign="top">guideRNA (5’–3’)</th><th align="left" valign="top">F primer (5’–3’)</th><th align="left" valign="top">R primer (5’–3’)</th><th align="left" valign="top">Enzyme</th></tr></thead><tbody><tr><td align="left" valign="top">trib1</td><td align="left" valign="top">AGCCCGTGAGCAGATGTCCGCGG</td><td align="left" valign="top">TACGGGCATTTCACTTTCGG</td><td align="left" valign="top">GTGAGGATCCCAGGAGACC</td><td align="left" valign="top">SacII</td></tr><tr><td align="left" valign="top">trib3</td><td align="left" valign="top">TCAACTCGCTTCAGTCGCAGTGG</td><td align="left" valign="top">ACCTGTTCAATCTTGTTGTCACA</td><td align="left" valign="top">GGAAGGAGGCTGACTGAGTC</td><td align="left" valign="top">Mwol</td></tr><tr><td align="left" valign="top">cop1</td><td align="left" valign="top">CGAGCTGCTCCCGTTCTGAGCGG</td><td align="left" valign="top">TTCAATTATGTCAAGCACTCGG</td><td align="left" valign="top">CAAGGGTCTTTTCCTGCTTAAA</td><td align="left" valign="top">Hyp188I</td></tr></tbody></table></table-wrap><p>Injected F0 generation were raised to adulthood (~3 months until breeding age) before individual fish were outcrossed with a wildtype (Nacre) zebrafish line. A selection of the offspring (F1, 24 embryos) was genotyped at 2 dpf by extracting the pooled genomic DNA of three embryos with 8 replicates per pair mating. From the genomic DNA, PCR was performed using <italic>trib1</italic> primer pair and an overnight restriction digest with SacII (NEB) at 37°C (Key resources table). Digests were run on a 2% (wt/vol) agarose gel at 100 V, positive mutations identified by undigested sample bands.</p><p>Batches of F1 embryos that were positive for mutations were pooled and raised. When raised F1 reached adulthood (~3 months), fish were fin clipped and genotyped. PCR was performed on the genomic DNA and purified using QIAquick PCR Purification Kit (QIAGEN) sequencing identified specific mutations in each founder. A male fish with a 14-bp deletion (loss of <named-content content-type="sequence">AGCAGATGTCCGCG</named-content>) was outcrossed with female wildtype (Nacre) fish. Resulting F2 offspring were raised to adulthood and fin clipped and genotyped. Heterozygous <italic>trib1<sup>+/−</sup></italic> mutant zebrafish (allele number sh628) were in-crossed to generate <italic>trib1<sup>+/+</sup></italic>, <italic>trib1<sup>+/−</sup></italic>, and <italic>trib<sup>−/−</sup></italic> F3 sibling offspring that were used for Mm experiments.</p></sec><sec id="s4-6"><title>Cloning and whole-mount in situ hybridisation of trib 1, 2, and 3</title><p>RNA probes for zebrafish <italic>trib1</italic> (ENSDARG00000110963), <italic>trib2</italic> (ENSDARG00000068179), and <italic>trib3</italic> (ENSDARG00000016200) were designed and synthesised after cloning the full-length genes into the pCRBlunt II-TOPO vector according to the instructions (ThermoFisher). Plasmid was linearised with the relevant restriction enzyme (<italic>trib1</italic>: HindIII, <italic>trib2</italic>: BsrGI, <italic>trib3</italic>: BsrGI) (NEB) and probes were synthesised according to DIG RNA Labelling Kit (SP6/T7, Roche, Merck). Zebrafish larvae were anaesthetised in 0.168 mg/ml Tricaine (MS-222, Sigma, Merck) in E3 media, which was removed and replaced with 4% (vol/vol in phosphate-buffered saline [PBS]) paraformaldehyde solution (Thermo Fisher) overnight at 4°C to fix. Whole-mount in situ hybridisation was performed as previously described (<xref ref-type="bibr" rid="bib73">Thisse and Thisse, 2008</xref>).</p></sec><sec id="s4-7"><title>RNA injections for trib overexpression experiments</title><p>Forward inserts of <italic>trib1</italic>, <italic>trib2</italic>, and <italic>trib3</italic> were cut from the pCRBlunt II-TOPO constructs using a double restriction digest with BamHI and XbaI at 37°C for 1.5 hr. The expression vector pCS2+ (Addgene) was digested using the same restriction enzyme pair and all digests were gel extracted using QIAquick Gel Extraction Kit (QIAGEN). Gel extracts of vector and <italic>trib</italic> digests were ligated into pCS2+ via overnight incubation at room temperature with T4 DNA ligase according to the manufacturer’s instructions (NEB). Constructs were confirmed using sequencing performed by the University of Sheffield’s Genomics core facility. RNA of each <italic>trib</italic> isoform was transcribed using mMessageMachine kit (Invitrogen) and diluted to 100 ng/μl in PR (diluted 1:10 in RNAse free water) for microinjection. Embryos were microinjected with 1 nl of 100 ng/μl RNA (measured using a 10-mm graticule) at the single-cell stage as previously described (<xref ref-type="bibr" rid="bib18">Elks et al., 2011</xref>). RNA of dominant active (DA) and negative (DN) <italic>hif-1ab</italic> variants (ZFIN: hif1ab) were used for controls (<xref ref-type="bibr" rid="bib19">Elks et al., 2013</xref>; <xref ref-type="bibr" rid="bib18">Elks et al., 2011</xref>).</p></sec><sec id="s4-8"><title><italic>Mycobacterium marinum</italic> culture and injection</title><p>Bacterial infection experiments were performed using <italic>Mycobacterium marinum</italic> strain M (ATCC #BAA-535), containing the pSMT3-mCherry vector (<xref ref-type="bibr" rid="bib74">van der Sar et al., 2009</xref>). Liquid cultures were prepared from bacterial plates before washing in PBS and diluting in 2% (wt/vol) polyvinylpyrrolidone40 (PVP40, Sigma, Merck) for injection as described previously (<xref ref-type="bibr" rid="bib8">Benard et al., 2012</xref>). Injection inoculum was prepared to 100 colony-forming units (cfu)/nl for all burden experiments, loaded into borosilicate glass microcapillary injection needles (World Precision Instruments, pulled using a micropipette puller device, WPI) before microinjection into the circulation of 30 hpf zebrafish larvae via the caudal vein.</p><p>Prior to injection, zebrafish were anaesthetised in 0.168 mg/ml Tricaine (MS-222, Sigma, Merck) in E3 media and were transferred onto 1% agarose in E3 + methylene blue plates, removing excess media. All pathogens were injected using a microinjection rig (WPI) attached to a dissecting microscope. A 10-mm graticule was used to measure 1 nl droplets of injection volume, and for consistency, droplets were tested every 5–10 fish and the needle recalibrated if necessary. After injection, zebrafish were transferred to fresh E3 media for recovery and maintained at 28°C.</p></sec><sec id="s4-9"><title>Anti-nitrotyrosine immunostaining</title><p>Larvae were fixed in 4% (vol/vol) paraformaldehyde in PBS overnight at 4°C, and nitrotyrosine levels were immune labelled using immunostaining with a rabbit polyclonal anti-nitrotyrosine antibody (Merck) and detected using an Alexa Fluor-conjugated secondary antibody (Thermo Fisher) as previously described (<xref ref-type="bibr" rid="bib20">Elks et al., 2014</xref>; <xref ref-type="bibr" rid="bib19">Elks et al., 2013</xref>).</p></sec><sec id="s4-10"><title>Confocal microscopy</title><p><italic>TgBAC(il-1β:GFP)sh445</italic> larvae and larvae immune-stained for nitrotyrosine were imaged using a Leica DMi8 SPE-TCS microscope using a HCX PL APO 40×/1.10 water immersion lens. Larvae were anaesthetised in 0.168 mg/ml Tricaine and mounted in 1% (wt/vol) low-melting agarose (Sigma, Merck) containing 0.168 mg/ml tricaine (Sigma, Merck) in 15μ-Slide 4 well glass bottom slides (Ibidi).</p></sec><sec id="s4-11"><title>Stereo microscopy</title><p>Zebrafish larvae were anaesthetised in 0.168 mg/ml Tricaine and transferred to a 50-mm glass bottomed FluoroDish (Ibidi). Zebrafish were imaged using a Leica DMi8 SPE-TCS microscope fitted with a Hamamatsu ORCA Flash 4.0 camera attachment using a HC FL PLAN 2.5×/0.07 dry lens. Whole-mount in situ staining was imaged using a Leica MZ10F stereo 14 microscope fitted with a GXCAM-U3 series 5MP camera (GT Vision).</p></sec><sec id="s4-12"><title>Image analysis</title><p>To calculate bacterial burden, fluorescent pixel count was measured using dedicated pixel count software (<xref ref-type="bibr" rid="bib71">Stoop et al., 2011</xref>). For confocal imaging of anti-nitrotyrosine staining or transgenic lines, ImageJ (<xref ref-type="bibr" rid="bib66">Schindelin et al., 2012</xref>) was used to quantify corrected total cell fluorescence (<xref ref-type="bibr" rid="bib20">Elks et al., 2014</xref>; <xref ref-type="bibr" rid="bib19">Elks et al., 2013</xref>).</p></sec><sec id="s4-13"><title>Statistical analysis</title><p>Statistical significance was calculated and determined using GraphPad Prism 10.0. Quantified data figures display all data points, with error bars depicting standard error of the mean unless stated otherwise in the figure legend. Statistical significance was determined using one-way analysis of variance with Bonferroni’s multiple comparisons post hoc test/Kruskal–Wallis for experiments with three or more experimental groups, or paired/unpaired <italic>T</italic>-test/Wilcoxon matched pairs signed rank test for experiments with two experimental groups, unless stated otherwise in figure legend. p values shown are: *p &lt; 0.05, **p &lt; 0.01, and ***p &lt; 0.001.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Resources, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Resources, Data curation, Formal analysis, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Resources, Data curation, Formal analysis, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Resources, Data curation, Formal analysis, Funding acquisition, Validation, Investigation, Visualization, Methodology, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Zebrafish were raised in The Biological Services Aquarium (University of Sheffield, UK) and maintained according to standard protocols (https://zfin.org/) in Home Office approved facilities. All procedures were performed on embryos pre 5.2 days post fertilisation (dpf) which were therefore outside of the Animals (Scientific Procedures) Act, to standards set by the UK Home Office. This work was performed under a UK Home Office Project Licence (PP7684817).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-95980-mdarchecklist1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript, supporting files and source data. Expression data was derived from publicly available transcriptomic data deposited in EBI ArrayExpress repository (datasets E-MTAB-8162 and E-MTAB-6816 respectively - <ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/biostudies/arrayexpress">https://www.ebi.ac.uk/biostudies/arrayexpress</ext-link><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/biostudies/arrayexpress">https://www.ebi.ac.uk/biostudies/arrayexpress</ext-link>). Original gel images can be found in Figure 4—figure supplement 2—source data 1,2, Figure 4—figure supplement 3—source data 1 and Figure 8—figure supplement 1—source data 1. Figure 1—source data 1–9, Figure 4—source data 1–5, Figure 4—figure supplement 3—source data 2, Figure 5—source data 1–6, Figure 6—source data 1,2, Figure 8—source data 1,2, and Figure 8—figure supplement 1—source data 2 contain the numerical data used to generate the figures.</p><p>The following previously published datasets were used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset1"><person-group person-group-type="author"><name><surname>Pollara</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Monocytes from people with active or latent TB stimulated in vitro with PPD</data-title><source>EBI ArrayExpress</source><pub-id pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-MTAB-8162">E-MTAB-8162</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Pollara</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Transcriptional profiling of the tuberculin skin test in patients with active and latent tuberculosis</data-title><source>EBI ArrayExpress</source><pub-id pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-MTAB-6816">E-MTAB-6816</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>The authors would like to thank Dr Heba Ismail, The University of Sheffield, for her expertise and helpful advice on E3 ubiquitin ligases. Thanks also to The Biological Services Aquarium Team at the University of Sheffield for their expert assistance with zebrafish husbandry. This work was supported by a University of Sheffield PhD scholarship awarded to FRH, PME, and AL are funded by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant Number 105570/Z/14/Z/A). MN was funded by the Wellcome Trust (WT101766/Z/13/Z to GP and 207511/Z/17/Z to MN), Medical Research Council (MR_N007727_1 to GST), Academy of Medical Sciences (SGL021\1045) to GP, and National Institute for Health Research Biomedical Research Centre at University College London Hospitals funding. Zebrafish infection work was performed in The Wolfson Laboratories for Zebrafish Models of Infection (The Wolfson Foundation/Royal Society grant number WLR\R1\170024) at the University of Sheffield.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>F</given-names></name><name><surname>Rani</surname><given-names>A</given-names></name><name><surname>Alam</surname><given-names>A</given-names></name><name><surname>Zarin</surname><given-names>S</given-names></name><name><surname>Pandey</surname><given-names>S</given-names></name><name><surname>Singh</surname><given-names>H</given-names></name><name><surname>Hasnain</surname><given-names>SE</given-names></name><name><surname>Ehtesham</surname><given-names>NZ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Macrophage: a cell with many faces and functions in tuberculosis</article-title><source>Frontiers in Immunology</source><volume>13</volume><elocation-id>747799</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2022.747799</pub-id><pub-id pub-id-type="pmid">35603185</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allué-Guardia</surname><given-names>A</given-names></name><name><surname>Saranathan</surname><given-names>R</given-names></name><name><surname>Chan</surname><given-names>J</given-names></name><name><surname>Torrelles</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Mycobacteriophages as potential therapeutic agents against drug-resistant tuberculosis</article-title><source>International Journal of Molecular Sciences</source><volume>22</volume><elocation-id>E735</elocation-id><pub-id pub-id-type="doi">10.3390/ijms22020735</pub-id><pub-id pub-id-type="pmid">33450990</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angyal</surname><given-names>A</given-names></name><name><surname>Kiss-Toth</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The tribbles gene family and lipoprotein metabolism</article-title><source>Current Opinion in Lipidology</source><volume>23</volume><fpage>122</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1097/MOL.0b013e3283508c3b</pub-id><pub-id pub-id-type="pmid">22274752</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arndt</surname><given-names>L</given-names></name><name><surname>Dokas</surname><given-names>J</given-names></name><name><surname>Gericke</surname><given-names>M</given-names></name><name><surname>Kutzner</surname><given-names>CE</given-names></name><name><surname>Müller</surname><given-names>S</given-names></name><name><surname>Jeromin</surname><given-names>F</given-names></name><name><surname>Thiery</surname><given-names>J</given-names></name><name><surname>Burkhardt</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Tribbles homolog 1 deficiency modulates function and polarization of murine bone marrow-derived macrophages</article-title><source>The Journal of Biological Chemistry</source><volume>293</volume><fpage>11527</fpage><lpage>11536</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA117.000703</pub-id><pub-id pub-id-type="pmid">29899113</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Athanasiadis</surname><given-names>EI</given-names></name><name><surname>Botthof</surname><given-names>JG</given-names></name><name><surname>Andres</surname><given-names>H</given-names></name><name><surname>Ferreira</surname><given-names>L</given-names></name><name><surname>Lio</surname><given-names>P</given-names></name><name><surname>Cvejic</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Single-cell RNA-sequencing uncovers transcriptional states and fate decisions in haematopoiesis</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>2045</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-02305-6</pub-id><pub-id pub-id-type="pmid">29229905</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balla</surname><given-names>KM</given-names></name><name><surname>Lugo-Villarino</surname><given-names>G</given-names></name><name><surname>Spitsbergen</surname><given-names>JM</given-names></name><name><surname>Stachura</surname><given-names>DL</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Bañuelos</surname><given-names>K</given-names></name><name><surname>Romo-Fewell</surname><given-names>O</given-names></name><name><surname>Aroian</surname><given-names>RV</given-names></name><name><surname>Traver</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Eosinophils in the zebrafish: prospective isolation, characterization, and eosinophilia induction by helminth determinants</article-title><source>Blood</source><volume>116</volume><fpage>3944</fpage><lpage>3954</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-03-267419</pub-id><pub-id pub-id-type="pmid">20713961</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname><given-names>LCK</given-names></name><name><surname>Pollara</surname><given-names>G</given-names></name><name><surname>Pascoe</surname><given-names>M</given-names></name><name><surname>Tomlinson</surname><given-names>GS</given-names></name><name><surname>Lehloenya</surname><given-names>RJ</given-names></name><name><surname>Roe</surname><given-names>J</given-names></name><name><surname>Meldau</surname><given-names>R</given-names></name><name><surname>Miller</surname><given-names>RF</given-names></name><name><surname>Ramsay</surname><given-names>A</given-names></name><name><surname>Chain</surname><given-names>BM</given-names></name><name><surname>Dheda</surname><given-names>K</given-names></name><name><surname>Noursadeghi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>In vivo molecular dissection of the effects of HIV-1 in Active Tuberculosis</article-title><source>PLOS Pathogens</source><volume>12</volume><elocation-id>e1005469</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1005469</pub-id><pub-id pub-id-type="pmid">26986567</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benard</surname><given-names>EL</given-names></name><name><surname>van der Sar</surname><given-names>AM</given-names></name><name><surname>Ellett</surname><given-names>F</given-names></name><name><surname>Lieschke</surname><given-names>GJ</given-names></name><name><surname>Spaink</surname><given-names>HP</given-names></name><name><surname>Meijer</surname><given-names>AH</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Infection of zebrafish embryos with intracellular bacterial pathogens</article-title><source>Journal of Visualized Experiments</source><volume>01</volume><elocation-id>3781</elocation-id><pub-id pub-id-type="doi">10.3791/3781</pub-id><pub-id pub-id-type="pmid">22453760</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernut</surname><given-names>A</given-names></name><name><surname>Dupont</surname><given-names>C</given-names></name><name><surname>Ogryzko</surname><given-names>NV</given-names></name><name><surname>Neyret</surname><given-names>A</given-names></name><name><surname>Herrmann</surname><given-names>JL</given-names></name><name><surname>Floto</surname><given-names>RA</given-names></name><name><surname>Renshaw</surname><given-names>SA</given-names></name><name><surname>Kremer</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>CFTR protects against mycobacterium abscessus infection by fine-tuning host oxidative defenses</article-title><source>Cell Reports</source><volume>26</volume><fpage>1828</fpage><lpage>1840</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.01.071</pub-id><pub-id pub-id-type="pmid">30759393</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bojarczuk</surname><given-names>A</given-names></name><name><surname>Miller</surname><given-names>KA</given-names></name><name><surname>Hotham</surname><given-names>R</given-names></name><name><surname>Lewis</surname><given-names>A</given-names></name><name><surname>Ogryzko</surname><given-names>NV</given-names></name><name><surname>Kamuyango</surname><given-names>AA</given-names></name><name><surname>Frost</surname><given-names>H</given-names></name><name><surname>Gibson</surname><given-names>RH</given-names></name><name><surname>Stillman</surname><given-names>E</given-names></name><name><surname>May</surname><given-names>RC</given-names></name><name><surname>Renshaw</surname><given-names>SA</given-names></name><name><surname>Johnston</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cryptococcus neoformans intracellular proliferation and capsule size determines early macrophage control of infection</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>21489</elocation-id><pub-id pub-id-type="doi">10.1038/srep21489</pub-id><pub-id pub-id-type="pmid">26887656</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buchan</surname><given-names>KD</given-names></name><name><surname>Prajsnar</surname><given-names>TK</given-names></name><name><surname>Ogryzko</surname><given-names>NV</given-names></name><name><surname>de Jong</surname><given-names>NWM</given-names></name><name><surname>van Gent</surname><given-names>M</given-names></name><name><surname>Kolata</surname><given-names>J</given-names></name><name><surname>Foster</surname><given-names>SJ</given-names></name><name><surname>van Strijp</surname><given-names>JAG</given-names></name><name><surname>Renshaw</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A transgenic zebrafish line for in vivo visualisation of neutrophil myeloperoxidase</article-title><source>PLOS ONE</source><volume>14</volume><elocation-id>e0215592</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0215592</pub-id><pub-id pub-id-type="pmid">31002727</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>X</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Zou</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Phosphorylation of CHOP (C/EBP Homologous Protein) by the AMP-activated protein Kinase Alpha 1 in macrophages promotes chop degradation and reduces injury-induced neointimal disruption in vivo</article-title><source>Circulation Research</source><volume>119</volume><fpage>1089</fpage><lpage>1100</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.116.309463</pub-id><pub-id pub-id-type="pmid">27650555</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dal</surname><given-names>N-JK</given-names></name><name><surname>Kocere</surname><given-names>A</given-names></name><name><surname>Wohlmann</surname><given-names>J</given-names></name><name><surname>Van Herck</surname><given-names>S</given-names></name><name><surname>Bauer</surname><given-names>TA</given-names></name><name><surname>Resseguier</surname><given-names>J</given-names></name><name><surname>Bagherifam</surname><given-names>S</given-names></name><name><surname>Hyldmo</surname><given-names>H</given-names></name><name><surname>Barz</surname><given-names>M</given-names></name><name><surname>De Geest</surname><given-names>BG</given-names></name><name><surname>Fenaroli</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Zebrafish embryos allow prediction of nanoparticle circulation times in mice and facilitate quantification of nanoparticle-cell interactions</article-title><source>Small</source><volume>16</volume><elocation-id>e1906719</elocation-id><pub-id pub-id-type="doi">10.1002/smll.201906719</pub-id><pub-id pub-id-type="pmid">31943784</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daniel</surname><given-names>J</given-names></name><name><surname>Maamar</surname><given-names>H</given-names></name><name><surname>Deb</surname><given-names>C</given-names></name><name><surname>Sirakova</surname><given-names>TD</given-names></name><name><surname>Kolattukudy</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages</article-title><source>PLOS Pathogens</source><volume>7</volume><elocation-id>e1002093</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1002093</pub-id><pub-id pub-id-type="pmid">21731490</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>R</given-names></name><name><surname>Sebo</surname><given-names>Z</given-names></name><name><surname>Pence</surname><given-names>L</given-names></name><name><surname>Dobens</surname><given-names>LL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title><italic>Drosophila</italic> tribbles antagonizes insulin signaling-mediated growth and metabolism via interactions with Akt kinase</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e109530</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0109530</pub-id><pub-id pub-id-type="pmid">25329475</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>JM</given-names></name><name><surname>Clay</surname><given-names>H</given-names></name><name><surname>Lewis</surname><given-names>JL</given-names></name><name><surname>Ghori</surname><given-names>N</given-names></name><name><surname>Herbomel</surname><given-names>P</given-names></name><name><surname>Ramakrishnan</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Real-time visualization of mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos</article-title><source>Immunity</source><volume>17</volume><fpage>693</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.1016/s1074-7613(02)00475-2</pub-id><pub-id pub-id-type="pmid">12479816</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durzynska</surname><given-names>I</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Adelmant</surname><given-names>G</given-names></name><name><surname>Ficarro</surname><given-names>SB</given-names></name><name><surname>Marto</surname><given-names>JA</given-names></name><name><surname>Sliz</surname><given-names>P</given-names></name><name><surname>Uljon</surname><given-names>S</given-names></name><name><surname>Blacklow</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>STK40 Is a Pseudokinase that binds the E3 ubiquitin ligase COP1</article-title><source>Structure</source><volume>25</volume><fpage>287</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1016/j.str.2016.12.008</pub-id><pub-id pub-id-type="pmid">28089446</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elks</surname><given-names>PM</given-names></name><name><surname>Loynes</surname><given-names>CA</given-names></name><name><surname>Renshaw</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Measuring inflammatory cell migration in the zebrafish</article-title><source>Methods in Molecular Biology</source><volume>769</volume><fpage>261</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1007/978-1-61779-207-6_18</pub-id><pub-id pub-id-type="pmid">21748682</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elks</surname><given-names>PM</given-names></name><name><surname>Brizee</surname><given-names>S</given-names></name><name><surname>van der Vaart</surname><given-names>M</given-names></name><name><surname>Walmsley</surname><given-names>SR</given-names></name><name><surname>van Eeden</surname><given-names>FJ</given-names></name><name><surname>Renshaw</surname><given-names>SA</given-names></name><name><surname>Meijer</surname><given-names>AH</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Hypoxia inducible factor signaling modulates susceptibility to mycobacterial infection via a nitric oxide dependent mechanism</article-title><source>PLOS Pathogens</source><volume>9</volume><elocation-id>e1003789</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003789</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elks</surname><given-names>PM</given-names></name><name><surname>van der Vaart</surname><given-names>M</given-names></name><name><surname>van Hensbergen</surname><given-names>V</given-names></name><name><surname>Schutz</surname><given-names>E</given-names></name><name><surname>Redd</surname><given-names>MJ</given-names></name><name><surname>Murayama</surname><given-names>E</given-names></name><name><surname>Spaink</surname><given-names>HP</given-names></name><name><surname>Meijer</surname><given-names>AH</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mycobacteria counteract a TLR-mediated nitrosative defense mechanism in a zebrafish infection model</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e100928</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0100928</pub-id><pub-id pub-id-type="pmid">24967596</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forlenza</surname><given-names>M</given-names></name><name><surname>Scharsack</surname><given-names>JP</given-names></name><name><surname>Kachamakova</surname><given-names>NM</given-names></name><name><surname>Taverne-Thiele</surname><given-names>AJ</given-names></name><name><surname>Rombout</surname><given-names>JHWM</given-names></name><name><surname>Wiegertjes</surname><given-names>GF</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Differential contribution of neutrophilic granulocytes and macrophages to nitrosative stress in a host-parasite animal model</article-title><source>Mol Immunol</source><volume>45</volume><fpage>3178</fpage><lpage>3189</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2008.02.025</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grosshans</surname><given-names>J</given-names></name><name><surname>Wieschaus</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>A genetic link between morphogenesis and cell division during formation of the ventral furrow in <italic>Drosophila</italic></article-title><source>Cell</source><volume>101</volume><fpage>523</fpage><lpage>531</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)80862-4</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hackett</surname><given-names>EE</given-names></name><name><surname>Charles-Messance</surname><given-names>H</given-names></name><name><surname>O’Leary</surname><given-names>SM</given-names></name><name><surname>Gleeson</surname><given-names>LE</given-names></name><name><surname>Muñoz-Wolf</surname><given-names>N</given-names></name><name><surname>Case</surname><given-names>S</given-names></name><name><surname>Wedderburn</surname><given-names>A</given-names></name><name><surname>Johnston</surname><given-names>DGW</given-names></name><name><surname>Williams</surname><given-names>MA</given-names></name><name><surname>Smyth</surname><given-names>A</given-names></name><name><surname>Ouimet</surname><given-names>M</given-names></name><name><surname>Moore</surname><given-names>KJ</given-names></name><name><surname>Lavelle</surname><given-names>EC</given-names></name><name><surname>Corr</surname><given-names>SC</given-names></name><name><surname>Gordon</surname><given-names>SV</given-names></name><name><surname>Keane</surname><given-names>J</given-names></name><name><surname>Sheedy</surname><given-names>FJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title><italic>Mycobacterium tuberculosis</italic> limits host glycolysis and IL-1β by restriction of PFK-M via MicroRNA-21</article-title><source>Cell Reports</source><volume>30</volume><fpage>124</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.12.015</pub-id><pub-id pub-id-type="pmid">31914380</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hameed</surname><given-names>S</given-names></name><name><surname>Mahmood</surname><given-names>N</given-names></name><name><surname>Chaudhry</surname><given-names>MN</given-names></name><name><surname>Ahmad</surname><given-names>SR</given-names></name><name><surname>Rahman</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Molecular detection of mutations in isolates of multidrug resistant tuberculosis and tuberculosis suspects by multiplex allele specific PCR</article-title><source>Pakistan Journal of Pharmaceutical Sciences</source><volume>31</volume><fpage>2661</fpage><lpage>2666</lpage><pub-id pub-id-type="pmid">30587476</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammond</surname><given-names>FR</given-names></name><name><surname>Lewis</surname><given-names>A</given-names></name><name><surname>Speirs</surname><given-names>ZC</given-names></name><name><surname>Anderson</surname><given-names>HE</given-names></name><name><surname>Sipka</surname><given-names>T</given-names></name><name><surname>Williams</surname><given-names>LG</given-names></name><name><surname>Nguyen-Chi</surname><given-names>M</given-names></name><name><surname>Meijer</surname><given-names>AH</given-names></name><name><surname>Wiegertjes</surname><given-names>GF</given-names></name><name><surname>Elks</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>An arginase 2 promoter transgenic line illuminates immune cell polarisation in zebrafish</article-title><source>Disease Models &amp; Mechanisms</source><volume>16</volume><elocation-id>dmm049966</elocation-id><pub-id pub-id-type="doi">10.1242/dmm.049966</pub-id><pub-id pub-id-type="pmid">37078586</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hegedus</surname><given-names>Z</given-names></name><name><surname>Czibula</surname><given-names>A</given-names></name><name><surname>Kiss-Toth</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Tribbles: novel regulators of cell function; evolutionary aspects</article-title><source>Cellular and Molecular Life Sciences</source><volume>63</volume><fpage>1632</fpage><lpage>1641</lpage><pub-id pub-id-type="doi">10.1007/s00018-006-6007-9</pub-id><pub-id pub-id-type="pmid">16715410</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hegedus</surname><given-names>Z</given-names></name><name><surname>Czibula</surname><given-names>A</given-names></name><name><surname>Kiss-Toth</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Tribbles: a family of kinase-like proteins with potent signalling regulatory function</article-title><source>Cellular Signalling</source><volume>19</volume><fpage>238</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1016/j.cellsig.2006.06.010</pub-id><pub-id pub-id-type="pmid">16963228</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holla</surname><given-names>S</given-names></name><name><surname>Ghorpade</surname><given-names>DS</given-names></name><name><surname>Singh</surname><given-names>V</given-names></name><name><surname>Bansal</surname><given-names>K</given-names></name><name><surname>Balaji</surname><given-names>KN</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mycobacterium bovis BCG promotes tumor cell survival from tumor necrosis factor-α-induced apoptosis</article-title><source>Molecular Cancer</source><volume>13</volume><elocation-id>210</elocation-id><pub-id pub-id-type="doi">10.1186/1476-4598-13-210</pub-id><pub-id pub-id-type="pmid">25208737</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>B</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Cai</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Gong</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>TRIB3 promotes the proliferation and invasion of renal cell carcinoma cells via activating MAPK signaling pathway</article-title><source>International Journal of Biological Sciences</source><volume>15</volume><fpage>587</fpage><lpage>597</lpage><pub-id pub-id-type="doi">10.7150/ijbs.29737</pub-id><pub-id pub-id-type="pmid">30745845</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hruscha</surname><given-names>A</given-names></name><name><surname>Krawitz</surname><given-names>P</given-names></name><name><surname>Rechenberg</surname><given-names>A</given-names></name><name><surname>Heinrich</surname><given-names>V</given-names></name><name><surname>Hecht</surname><given-names>J</given-names></name><name><surname>Haass</surname><given-names>C</given-names></name><name><surname>Schmid</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish</article-title><source>Developmen</source><volume>140</volume><fpage>4982</fpage><lpage>4987</lpage><pub-id pub-id-type="doi">10.1242/dev.099085</pub-id><pub-id pub-id-type="pmid">24257628</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isles</surname><given-names>HM</given-names></name><name><surname>Herman</surname><given-names>KD</given-names></name><name><surname>Robertson</surname><given-names>AL</given-names></name><name><surname>Loynes</surname><given-names>CA</given-names></name><name><surname>Prince</surname><given-names>LR</given-names></name><name><surname>Elks</surname><given-names>PM</given-names></name><name><surname>Renshaw</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The CXCL12/CXCR4 signaling axis retains neutrophils at inflammatory sites in Zebrafish</article-title><source>Frontiers in Immunology</source><volume>10</volume><elocation-id>1784</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.01784</pub-id><pub-id pub-id-type="pmid">31417560</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamieson</surname><given-names>SA</given-names></name><name><surname>Ruan</surname><given-names>Z</given-names></name><name><surname>Burgess</surname><given-names>AE</given-names></name><name><surname>Curry</surname><given-names>JR</given-names></name><name><surname>McMillan</surname><given-names>HD</given-names></name><name><surname>Brewster</surname><given-names>JL</given-names></name><name><surname>Dunbier</surname><given-names>AK</given-names></name><name><surname>Axtman</surname><given-names>AD</given-names></name><name><surname>Kannan</surname><given-names>N</given-names></name><name><surname>Mace</surname><given-names>PD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Substrate binding allosterically relieves autoinhibition of the pseudokinase TRIB1</article-title><source>Science Signaling</source><volume>11</volume><elocation-id>eaau0597</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.aau0597</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>J</given-names></name><name><surname>Basatvat</surname><given-names>S</given-names></name><name><surname>Ilyas</surname><given-names>Z</given-names></name><name><surname>Francis</surname><given-names>S</given-names></name><name><surname>Kiss-Toth</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Tribbles in inflammation</article-title><source>Biochemical Society Transactions</source><volume>43</volume><fpage>1069</fpage><lpage>1074</lpage><pub-id pub-id-type="doi">10.1042/BST20150095</pub-id><pub-id pub-id-type="pmid">26517925</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>JM</given-names></name><name><surname>Angyal</surname><given-names>A</given-names></name><name><surname>Bauer</surname><given-names>RC</given-names></name><name><surname>Hamby</surname><given-names>S</given-names></name><name><surname>Suvarna</surname><given-names>SK</given-names></name><name><surname>Baidžajevas</surname><given-names>K</given-names></name><name><surname>Hegedus</surname><given-names>Z</given-names></name><name><surname>Dear</surname><given-names>TN</given-names></name><name><surname>Turner</surname><given-names>M</given-names></name><collab>Cardiogenics Consortium</collab><name><surname>Wilson</surname><given-names>HL</given-names></name><name><surname>Goodall</surname><given-names>AH</given-names></name><name><surname>Rader</surname><given-names>DJ</given-names></name><name><surname>Shoulders</surname><given-names>CC</given-names></name><name><surname>Francis</surname><given-names>SE</given-names></name><name><surname>Kiss-Toth</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Myeloid Tribbles 1 induces early atherosclerosis via enhanced foam cell expansion</article-title><source>Science Advances</source><volume>5</volume><elocation-id>eaax9183</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aax9183</pub-id><pub-id pub-id-type="pmid">31692955</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jumper</surname><given-names>J</given-names></name><name><surname>Evans</surname><given-names>R</given-names></name><name><surname>Pritzel</surname><given-names>A</given-names></name><name><surname>Green</surname><given-names>T</given-names></name><name><surname>Figurnov</surname><given-names>M</given-names></name><name><surname>Ronneberger</surname><given-names>O</given-names></name><name><surname>Tunyasuvunakool</surname><given-names>K</given-names></name><name><surname>Bates</surname><given-names>R</given-names></name><name><surname>Žídek</surname><given-names>A</given-names></name><name><surname>Potapenko</surname><given-names>A</given-names></name><name><surname>Bridgland</surname><given-names>A</given-names></name><name><surname>Meyer</surname><given-names>C</given-names></name><name><surname>Kohl</surname><given-names>SAA</given-names></name><name><surname>Ballard</surname><given-names>AJ</given-names></name><name><surname>Cowie</surname><given-names>A</given-names></name><name><surname>Romera-Paredes</surname><given-names>B</given-names></name><name><surname>Nikolov</surname><given-names>S</given-names></name><name><surname>Jain</surname><given-names>R</given-names></name><name><surname>Adler</surname><given-names>J</given-names></name><name><surname>Back</surname><given-names>T</given-names></name><name><surname>Petersen</surname><given-names>S</given-names></name><name><surname>Reiman</surname><given-names>D</given-names></name><name><surname>Clancy</surname><given-names>E</given-names></name><name><surname>Zielinski</surname><given-names>M</given-names></name><name><surname>Steinegger</surname><given-names>M</given-names></name><name><surname>Pacholska</surname><given-names>M</given-names></name><name><surname>Berghammer</surname><given-names>T</given-names></name><name><surname>Bodenstein</surname><given-names>S</given-names></name><name><surname>Silver</surname><given-names>D</given-names></name><name><surname>Vinyals</surname><given-names>O</given-names></name><name><surname>Senior</surname><given-names>AW</given-names></name><name><surname>Kavukcuoglu</surname><given-names>K</given-names></name><name><surname>Kohli</surname><given-names>P</given-names></name><name><surname>Hassabis</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Highly accurate protein structure prediction with AlphaFold</article-title><source>Nature</source><volume>596</volume><fpage>583</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id><pub-id pub-id-type="pmid">34265844</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>E</given-names></name><name><surname>Sanz</surname><given-names>J</given-names></name><name><surname>Dunn</surname><given-names>JL</given-names></name><name><surname>Khan</surname><given-names>N</given-names></name><name><surname>Mendonça</surname><given-names>LE</given-names></name><name><surname>Pacis</surname><given-names>A</given-names></name><name><surname>Tzelepis</surname><given-names>F</given-names></name><name><surname>Pernet</surname><given-names>E</given-names></name><name><surname>Dumaine</surname><given-names>A</given-names></name><name><surname>Grenier</surname><given-names>JC</given-names></name><name><surname>Mailhot-Léonard</surname><given-names>F</given-names></name><name><surname>Ahmed</surname><given-names>E</given-names></name><name><surname>Belle</surname><given-names>J</given-names></name><name><surname>Besla</surname><given-names>R</given-names></name><name><surname>Mazer</surname><given-names>B</given-names></name><name><surname>King</surname><given-names>IL</given-names></name><name><surname>Nijnik</surname><given-names>A</given-names></name><name><surname>Robbins</surname><given-names>CS</given-names></name><name><surname>Barreiro</surname><given-names>LB</given-names></name><name><surname>Divangahi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis</article-title><source>Cell</source><volume>172</volume><fpage>176</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.12.031</pub-id><pub-id pub-id-type="pmid">29328912</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilinç</surname><given-names>G</given-names></name><name><surname>Saris</surname><given-names>A</given-names></name><name><surname>Ottenhoff</surname><given-names>THM</given-names></name><name><surname>Haks</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Host-directed therapy to combat mycobacterial infections</article-title><source>Immunological Reviews</source><volume>301</volume><fpage>62</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1111/imr.12951</pub-id><pub-id pub-id-type="pmid">33565103</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>KW</given-names></name><name><surname>Thakur</surname><given-names>N</given-names></name><name><surname>Piggott</surname><given-names>CA</given-names></name><name><surname>Omi</surname><given-names>S</given-names></name><name><surname>Polanowska</surname><given-names>J</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Pujol</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Coordinated inhibition of C/EBP by Tribbles in multiple tissues is essential for <italic>Caenorhabditis elegans</italic> development</article-title><source>BMC Biology</source><volume>14</volume><elocation-id>104</elocation-id><pub-id pub-id-type="doi">10.1186/s12915-016-0320-z</pub-id><pub-id pub-id-type="pmid">27927209</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiss-Toth</surname><given-names>E</given-names></name><name><surname>Bagstaff</surname><given-names>SM</given-names></name><name><surname>Sung</surname><given-names>HY</given-names></name><name><surname>Jozsa</surname><given-names>V</given-names></name><name><surname>Dempsey</surname><given-names>C</given-names></name><name><surname>Caunt</surname><given-names>JC</given-names></name><name><surname>Oxley</surname><given-names>KM</given-names></name><name><surname>Wyllie</surname><given-names>DH</given-names></name><name><surname>Polgar</surname><given-names>T</given-names></name><name><surname>Harte</surname><given-names>M</given-names></name><name><surname>O’neill</surname><given-names>LAJ</given-names></name><name><surname>Qwarnstrom</surname><given-names>EE</given-names></name><name><surname>Dower</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Human tribbles, a protein family controlling mitogen-activated protein kinase cascades</article-title><source>The Journal of Biological Chemistry</source><volume>279</volume><fpage>42703</fpage><lpage>42708</lpage><pub-id pub-id-type="doi">10.1074/jbc.M407732200</pub-id><pub-id pub-id-type="pmid">15299019</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knight</surname><given-names>M</given-names></name><name><surname>Braverman</surname><given-names>J</given-names></name><name><surname>Asfaha</surname><given-names>K</given-names></name><name><surname>Gronert</surname><given-names>K</given-names></name><name><surname>Stanley</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Lipid droplet formation in Mycobacterium tuberculosis infected macrophages requires IFN-γ/HIF-1α signaling and supports host defense</article-title><source>PLOS Pathogens</source><volume>14</volume><elocation-id>e1006874</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006874</pub-id><pub-id pub-id-type="pmid">29370315</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kung</surname><given-names>JE</given-names></name><name><surname>Jura</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The pseudokinase TRIB1 toggles an intramolecular switch to regulate COP1 nuclear export</article-title><source>The EMBO Journal</source><volume>38</volume><elocation-id>e99708</elocation-id><pub-id pub-id-type="doi">10.15252/embj.201899708</pub-id><pub-id pub-id-type="pmid">30692133</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>RPJ</given-names></name><name><surname>Meintjes</surname><given-names>G</given-names></name><name><surname>Wilkinson</surname><given-names>KA</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>Marais</surname><given-names>S</given-names></name><name><surname>Van der Plas</surname><given-names>H</given-names></name><name><surname>Deffur</surname><given-names>A</given-names></name><name><surname>Schutz</surname><given-names>C</given-names></name><name><surname>Bloom</surname><given-names>C</given-names></name><name><surname>Munagala</surname><given-names>I</given-names></name><name><surname>Anguiano</surname><given-names>E</given-names></name><name><surname>Goliath</surname><given-names>R</given-names></name><name><surname>Maartens</surname><given-names>G</given-names></name><name><surname>Banchereau</surname><given-names>J</given-names></name><name><surname>Chaussabel</surname><given-names>D</given-names></name><name><surname>O’Garra</surname><given-names>A</given-names></name><name><surname>Wilkinson</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>HIV-tuberculosis-associated immune reconstitution inflammatory syndrome is characterized by Toll-like receptor and inflammasome signalling</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>8451</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms9451</pub-id><pub-id pub-id-type="pmid">26399326</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>A</given-names></name><name><surname>Elks</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Hypoxia induces macrophage tnfa expression via cyclooxygenase and prostaglandin E2 in vivo</article-title><source>Frontiers in Immunology</source><volume>10</volume><elocation-id>2321</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.02321</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Kwok</surname><given-names>I</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Wen</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>P</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>He</surname><given-names>S</given-names></name><name><surname>Peng</surname><given-names>W</given-names></name><name><surname>Bei</surname><given-names>JX</given-names></name><name><surname>Ginhoux</surname><given-names>F</given-names></name><name><surname>Ng</surname><given-names>LG</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Cebp1 and Cebpβ transcriptional axis controls eosinophilopoiesis in zebrafish</article-title><source>Nature Communications</source><volume>15</volume><elocation-id>811</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-024-45029-0</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y-H</given-names></name><name><surname>Tan</surname><given-names>KAL</given-names></name><name><surname>Morrison</surname><given-names>IW</given-names></name><name><surname>Lamb</surname><given-names>JR</given-names></name><name><surname>Argyle</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Macrophage migration is controlled by Tribbles 1 through the interaction between C/EBPβ and TNF-α</article-title><source>Veterinary Immunology and Immunopathology</source><volume>155</volume><fpage>67</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/j.vetimm.2013.06.001</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyons</surname><given-names>SE</given-names></name><name><surname>Shue</surname><given-names>BC</given-names></name><name><surname>Oates</surname><given-names>AC</given-names></name><name><surname>Zon</surname><given-names>LI</given-names></name><name><surname>Liu</surname><given-names>PP</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>A novel myeloid-restricted zebrafish CCAAT/enhancer-binding protein with A potent transcriptional activation domain</article-title><source>Blood</source><volume>97</volume><fpage>2611</fpage><lpage>2617</lpage><pub-id pub-id-type="doi">10.1182/blood.v97.9.2611</pub-id><pub-id pub-id-type="pmid">11313249</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mack</surname><given-names>EA</given-names></name><name><surname>Stein</surname><given-names>SJ</given-names></name><name><surname>Rome</surname><given-names>KS</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Wertheim</surname><given-names>GB</given-names></name><name><surname>Melo</surname><given-names>RCN</given-names></name><name><surname>Pear</surname><given-names>WS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Trib1 regulates eosinophil lineage commitment and identity by restraining the neutrophil program</article-title><source>Blood</source><volume>133</volume><fpage>2413</fpage><lpage>2426</lpage><pub-id pub-id-type="doi">10.1182/blood.2018872218</pub-id><pub-id pub-id-type="pmid">30917956</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mata</surname><given-names>J</given-names></name><name><surname>Curado</surname><given-names>S</given-names></name><name><surname>Ephrussi</surname><given-names>A</given-names></name><name><surname>Rørth</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Tribbles coordinates mitosis and morphogenesis in <italic>Drosophila</italic> by regulating string/CDC25 proteolysis</article-title><source>Cell</source><volume>101</volume><fpage>511</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)80861-2</pub-id><pub-id pub-id-type="pmid">10850493</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menon</surname><given-names>D</given-names></name><name><surname>Singh</surname><given-names>K</given-names></name><name><surname>Pinto</surname><given-names>SM</given-names></name><name><surname>Nandy</surname><given-names>A</given-names></name><name><surname>Jaisinghani</surname><given-names>N</given-names></name><name><surname>Kutum</surname><given-names>R</given-names></name><name><surname>Dash</surname><given-names>D</given-names></name><name><surname>Prasad</surname><given-names>TSK</given-names></name><name><surname>Gandotra</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Quantitative lipid droplet proteomics reveals mycobacterium tuberculosis induced alterations in macrophage response to infection</article-title><source>ACS Infectious Diseases</source><volume>5</volume><fpage>559</fpage><lpage>569</lpage><pub-id pub-id-type="doi">10.1021/acsinfecdis.8b00301</pub-id><pub-id pub-id-type="pmid">30663302</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Migliori</surname><given-names>GB</given-names></name><name><surname>Centis</surname><given-names>R</given-names></name><name><surname>D’Ambrosio</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A case of resistance beyond extensively drug-resistant tuberculosis in Japan</article-title><source>The European Respiratory Journal</source><volume>42</volume><fpage>872</fpage><lpage>873</lpage><pub-id pub-id-type="doi">10.1183/09031936.00061113</pub-id><pub-id pub-id-type="pmid">24000259</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>JM</given-names></name><name><surname>Nakatani</surname><given-names>Y</given-names></name><name><surname>Jamieson</surname><given-names>SA</given-names></name><name><surname>Dai</surname><given-names>W</given-names></name><name><surname>Lucet</surname><given-names>IS</given-names></name><name><surname>Mace</surname><given-names>PD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Molecular mechanism of CCAAT-Enhancer binding protein recruitment by the TRIB1 Pseudokinase</article-title><source>Structure</source><volume>23</volume><fpage>2111</fpage><lpage>2121</lpage><pub-id pub-id-type="doi">10.1016/j.str.2015.08.017</pub-id><pub-id pub-id-type="pmid">26455797</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niespolo</surname><given-names>C</given-names></name><name><surname>Johnston</surname><given-names>JM</given-names></name><name><surname>Deshmukh</surname><given-names>SR</given-names></name><name><surname>Satam</surname><given-names>S</given-names></name><name><surname>Shologu</surname><given-names>Z</given-names></name><name><surname>Villacanas</surname><given-names>O</given-names></name><name><surname>Sudbery</surname><given-names>IM</given-names></name><name><surname>Wilson</surname><given-names>HL</given-names></name><name><surname>Kiss-Toth</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Tribbles-1 expression and its function to control inflammatory cytokines, including interleukin-8 levels are regulated by miRNAs in macrophages and prostate cancer cells</article-title><source>Frontiers in Immunology</source><volume>11</volume><elocation-id>574046</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.574046</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noguchi</surname><given-names>K</given-names></name><name><surname>Yokozeki</surname><given-names>K</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Nakajima</surname><given-names>K</given-names></name><name><surname>Nishimura</surname><given-names>T</given-names></name><name><surname>Goda</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Sima, a <italic>Drosophila</italic> homolog of HIF-1α, in fat body tissue inhibits larval body growth by inducing Tribbles gene expression</article-title><source>Genes Cells</source><volume>27</volume><fpage>145</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1111/gtc.12913</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogryzko</surname><given-names>NV</given-names></name><name><surname>Lewis</surname><given-names>A</given-names></name><name><surname>Wilson</surname><given-names>HL</given-names></name><name><surname>Meijer</surname><given-names>AH</given-names></name><name><surname>Renshaw</surname><given-names>SA</given-names></name><name><surname>Elks</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Hif-1α-induced expression of Il-1β protects against mycobacterial infection in Zebrafish</article-title><source>Journal of Immunology</source><volume>202</volume><fpage>494</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1801139</pub-id><pub-id pub-id-type="pmid">30552162</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Örd</surname><given-names>T</given-names></name><name><surname>Örd</surname><given-names>D</given-names></name><name><surname>Örd</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>TRIB3 limits FGF21 induction during in vitro and in vivo nutrient deficiencies by inhibiting C/EBP–ATF response elements in the FGF21 promoter</article-title><source>Biochimica et Biophysica Acta</source><volume>1861</volume><fpage>271</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1016/j.bbagrm.2018.01.014</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Örd</surname><given-names>T</given-names></name><name><surname>Puurand</surname><given-names>T</given-names></name><name><surname>Örd</surname><given-names>D</given-names></name><name><surname>Annilo</surname><given-names>T</given-names></name><name><surname>Möls</surname><given-names>M</given-names></name><name><surname>Remm</surname><given-names>M</given-names></name><name><surname>Örd</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A human-specific VNTR in the TRIB3 promoter causes gene expression variation between individuals</article-title><source>PLOS Genetics</source><volume>16</volume><elocation-id>e1008981</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1008981</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ostertag</surname><given-names>A</given-names></name><name><surname>Jones</surname><given-names>A</given-names></name><name><surname>Rose</surname><given-names>AJ</given-names></name><name><surname>Liebert</surname><given-names>M</given-names></name><name><surname>Kleinsorg</surname><given-names>S</given-names></name><name><surname>Reimann</surname><given-names>A</given-names></name><name><surname>Vegiopoulos</surname><given-names>A</given-names></name><name><surname>Berriel Diaz</surname><given-names>M</given-names></name><name><surname>Strzoda</surname><given-names>D</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name><name><surname>Satoh</surname><given-names>T</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name><name><surname>Herzig</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Control of adipose tissue inflammation through TRB1</article-title><source>Diabetes</source><volume>59</volume><fpage>1991</fpage><lpage>2000</lpage><pub-id pub-id-type="doi">10.2337/db09-1537</pub-id><pub-id pub-id-type="pmid">20522600</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettersen</surname><given-names>EF</given-names></name><name><surname>Goddard</surname><given-names>TD</given-names></name><name><surname>Huang</surname><given-names>CC</given-names></name><name><surname>Meng</surname><given-names>EC</given-names></name><name><surname>Couch</surname><given-names>GS</given-names></name><name><surname>Croll</surname><given-names>TI</given-names></name><name><surname>Morris</surname><given-names>JH</given-names></name><name><surname>Ferrin</surname><given-names>TE</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>UCSF ChimeraX: Structure visualization for researchers, educators, and developers</article-title><source>Protein Science</source><volume>30</volume><fpage>70</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1002/pro.3943</pub-id><pub-id pub-id-type="pmid">32881101</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollara</surname><given-names>G</given-names></name><name><surname>Turner</surname><given-names>CT</given-names></name><name><surname>Rosenheim</surname><given-names>J</given-names></name><name><surname>Chandran</surname><given-names>A</given-names></name><name><surname>Bell</surname><given-names>LCK</given-names></name><name><surname>Khan</surname><given-names>A</given-names></name><name><surname>Patel</surname><given-names>A</given-names></name><name><surname>Peralta</surname><given-names>LF</given-names></name><name><surname>Folino</surname><given-names>A</given-names></name><name><surname>Akarca</surname><given-names>A</given-names></name><name><surname>Venturini</surname><given-names>C</given-names></name><name><surname>Baker</surname><given-names>T</given-names></name><name><surname>Ecker</surname><given-names>S</given-names></name><name><surname>Ricciardolo</surname><given-names>FLM</given-names></name><name><surname>Marafioti</surname><given-names>T</given-names></name><name><surname>Ugarte-Gil</surname><given-names>C</given-names></name><name><surname>Moore</surname><given-names>DAJ</given-names></name><name><surname>Chain</surname><given-names>BM</given-names></name><name><surname>Tomlinson</surname><given-names>GS</given-names></name><name><surname>Noursadeghi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Exaggerated IL-17A activity in human in vivo recall responses discriminates active tuberculosis from latent infection and cured disease</article-title><source>Science Translational Medicine</source><volume>13</volume><elocation-id>eabg7673</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.abg7673</pub-id><pub-id pub-id-type="pmid">33952677</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prudente</surname><given-names>S</given-names></name><name><surname>Sesti</surname><given-names>G</given-names></name><name><surname>Pandolfi</surname><given-names>A</given-names></name><name><surname>Andreozzi</surname><given-names>F</given-names></name><name><surname>Consoli</surname><given-names>A</given-names></name><name><surname>Trischitta</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The mammalian tribbles homolog TRIB3, glucose homeostasis, and cardiovascular diseases</article-title><source>Endocrine Reviews</source><volume>33</volume><fpage>526</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1210/er.2011-1042</pub-id><pub-id pub-id-type="pmid">22577090</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>L</given-names></name><name><surname>Heredia</surname><given-names>JE</given-names></name><name><surname>Altarejos</surname><given-names>JY</given-names></name><name><surname>Screaton</surname><given-names>R</given-names></name><name><surname>Goebel</surname><given-names>N</given-names></name><name><surname>Niessen</surname><given-names>S</given-names></name><name><surname>MacLeod</surname><given-names>IX</given-names></name><name><surname>Liew</surname><given-names>CW</given-names></name><name><surname>Kulkarni</surname><given-names>RN</given-names></name><name><surname>Bain</surname><given-names>J</given-names></name><name><surname>Newgard</surname><given-names>C</given-names></name><name><surname>Nelson</surname><given-names>M</given-names></name><name><surname>Evans</surname><given-names>RM</given-names></name><name><surname>Yates</surname><given-names>J</given-names></name><name><surname>Montminy</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism</article-title><source>Science</source><volume>312</volume><fpage>1763</fpage><lpage>1766</lpage><pub-id pub-id-type="doi">10.1126/science.1123374</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renshaw</surname><given-names>SA</given-names></name><name><surname>Loynes</surname><given-names>CA</given-names></name><name><surname>Trushell</surname><given-names>DMI</given-names></name><name><surname>Elworthy</surname><given-names>S</given-names></name><name><surname>Ingham</surname><given-names>PW</given-names></name><name><surname>Whyte</surname><given-names>MKB</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A transgenic zebrafish model of neutrophilic inflammation</article-title><source>Blood</source><volume>108</volume><fpage>3976</fpage><lpage>3978</lpage><pub-id pub-id-type="doi">10.1182/blood-2006-05-024075</pub-id><pub-id pub-id-type="pmid">16926288</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santhakumar</surname><given-names>K</given-names></name><name><surname>Judson</surname><given-names>EC</given-names></name><name><surname>Elks</surname><given-names>PM</given-names></name><name><surname>McKee</surname><given-names>S</given-names></name><name><surname>Elworthy</surname><given-names>S</given-names></name><name><surname>van Rooijen</surname><given-names>E</given-names></name><name><surname>Walmsley</surname><given-names>SS</given-names></name><name><surname>Renshaw</surname><given-names>SA</given-names></name><name><surname>Cross</surname><given-names>SS</given-names></name><name><surname>van Eeden</surname><given-names>FJM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A zebrafish model to study and therapeutically manipulate hypoxia signaling in tumorigenesis</article-title><source>Cancer Research</source><volume>72</volume><fpage>4017</fpage><lpage>4027</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-11-3148</pub-id><pub-id pub-id-type="pmid">22665266</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satoh</surname><given-names>T</given-names></name><name><surname>Kidoya</surname><given-names>H</given-names></name><name><surname>Naito</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name><name><surname>Takemura</surname><given-names>N</given-names></name><name><surname>Nakagawa</surname><given-names>K</given-names></name><name><surname>Yoshioka</surname><given-names>Y</given-names></name><name><surname>Morii</surname><given-names>E</given-names></name><name><surname>Takakura</surname><given-names>N</given-names></name><name><surname>Takeuchi</surname><given-names>O</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Critical role of Trib1 in differentiation of tissue-resident M2-like macrophages</article-title><source>Nature</source><volume>495</volume><fpage>524</fpage><lpage>528</lpage><pub-id pub-id-type="doi">10.1038/nature11930</pub-id><pub-id pub-id-type="pmid">23515163</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schild</surname><given-names>Y</given-names></name><name><surname>Mohamed</surname><given-names>A</given-names></name><name><surname>Wootton</surname><given-names>EJ</given-names></name><name><surname>Lewis</surname><given-names>A</given-names></name><name><surname>Elks</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Hif-1alpha stabilisation is protective against infection in zebrafish comorbid models</article-title><source>The FEBS Journal</source><volume>287</volume><fpage>3925</fpage><lpage>3943</lpage><pub-id pub-id-type="doi">10.1111/febs.15433</pub-id><pub-id pub-id-type="pmid">32485057</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname><given-names>J</given-names></name><name><surname>Arganda-Carreras</surname><given-names>I</given-names></name><name><surname>Frise</surname><given-names>E</given-names></name><name><surname>Kaynig</surname><given-names>V</given-names></name><name><surname>Longair</surname><given-names>M</given-names></name><name><surname>Pietzsch</surname><given-names>T</given-names></name><name><surname>Preibisch</surname><given-names>S</given-names></name><name><surname>Rueden</surname><given-names>C</given-names></name><name><surname>Saalfeld</surname><given-names>S</given-names></name><name><surname>Schmid</surname><given-names>B</given-names></name><name><surname>Tinevez</surname><given-names>JY</given-names></name><name><surname>White</surname><given-names>DJ</given-names></name><name><surname>Hartenstein</surname><given-names>V</given-names></name><name><surname>Eliceiri</surname><given-names>K</given-names></name><name><surname>Tomancak</surname><given-names>P</given-names></name><name><surname>Cardona</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoolmeesters</surname><given-names>A</given-names></name><name><surname>Brown</surname><given-names>DD</given-names></name><name><surname>Fedorov</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Kinome-wide functional genomics screen reveals a novel mechanism of TNFα-induced nuclear accumulation of the HIF-1α transcription factor in cancer cells</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e31270</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0031270</pub-id><pub-id pub-id-type="pmid">22355351</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seher</surname><given-names>TC</given-names></name><name><surname>Leptin</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Tribbles, a cell-cycle brake that coordinates proliferation and morphogenesis during <italic>Drosophila</italic> gastrulation</article-title><source>Current Biology</source><volume>10</volume><fpage>623</fpage><lpage>629</lpage><pub-id pub-id-type="doi">10.1016/S0960-9822(00)00502-9</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheedy</surname><given-names>FJ</given-names></name><name><surname>Divangahi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Targeting immunometabolism in host defence against Mycobacterium tuberculosis</article-title><source>Immunology</source><volume>162</volume><fpage>145</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1111/imm.13276</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steverson</surname><given-names>D</given-names></name><name><surname>Tian</surname><given-names>L</given-names></name><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Ma</surname><given-names>E</given-names></name><name><surname>Garvey</surname><given-names>WT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Tribbles homolog 3 promotes foam cell formation associated with decreased proinflammatory cytokine production in macrophages: Evidence for reciprocal regulation of cholesterol uptake and inflammation</article-title><source>Metabolic Syndrome and Related Disorders</source><volume>14</volume><fpage>7</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1089/met.2015.0037</pub-id><pub-id pub-id-type="pmid">26584255</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoop</surname><given-names>EJM</given-names></name><name><surname>Schipper</surname><given-names>T</given-names></name><name><surname>Rosendahl Huber</surname><given-names>SK</given-names></name><name><surname>Nezhinsky</surname><given-names>AE</given-names></name><name><surname>Verbeek</surname><given-names>FJ</given-names></name><name><surname>Gurcha</surname><given-names>SS</given-names></name><name><surname>Besra</surname><given-names>GS</given-names></name><name><surname>Vandenbroucke-Grauls</surname><given-names>CMJE</given-names></name><name><surname>Bitter</surname><given-names>W</given-names></name><name><surname>van der Sar</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Zebrafish embryo screen for mycobacterial genes involved in the initiation of granuloma formation reveals a newly identified ESX-1 component</article-title><source>Disease Models &amp; Mechanisms</source><volume>4</volume><fpage>526</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.1242/dmm.006676</pub-id><pub-id pub-id-type="pmid">21372049</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>Y</given-names></name><name><surname>Ohoka</surname><given-names>N</given-names></name><name><surname>Hayashi</surname><given-names>H</given-names></name><name><surname>Sato</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>TRB3 suppresses adipocyte differentiation by negatively regulating PPARgamma transcriptional activity</article-title><source>Journal of Lipid Research</source><volume>49</volume><fpage>880</fpage><lpage>892</lpage><pub-id pub-id-type="doi">10.1194/jlr.M700545-JLR200</pub-id><pub-id pub-id-type="pmid">18187772</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thisse</surname><given-names>C</given-names></name><name><surname>Thisse</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>High-resolution in situ hybridization to whole-mount zebrafish embryos</article-title><source>Nature Protocols</source><volume>3</volume><fpage>59</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1038/nprot.2007.514</pub-id><pub-id pub-id-type="pmid">18193022</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Sar</surname><given-names>AM</given-names></name><name><surname>Spaink</surname><given-names>HP</given-names></name><name><surname>Zakrzewska</surname><given-names>A</given-names></name><name><surname>Bitter</surname><given-names>W</given-names></name><name><surname>Meijer</surname><given-names>AH</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Specificity of the zebrafish host transcriptome response to acute and chronic mycobacterial infection and the role of innate and adaptive immune components</article-title><source>Molecular Immunology</source><volume>46</volume><fpage>2317</fpage><lpage>2332</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2009.03.024</pub-id><pub-id pub-id-type="pmid">19409617</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varadi</surname><given-names>M</given-names></name><name><surname>Anyango</surname><given-names>S</given-names></name><name><surname>Deshpande</surname><given-names>M</given-names></name><name><surname>Nair</surname><given-names>S</given-names></name><name><surname>Natassia</surname><given-names>C</given-names></name><name><surname>Yordanova</surname><given-names>G</given-names></name><name><surname>Yuan</surname><given-names>D</given-names></name><name><surname>Stroe</surname><given-names>O</given-names></name><name><surname>Wood</surname><given-names>G</given-names></name><name><surname>Laydon</surname><given-names>A</given-names></name><name><surname>Žídek</surname><given-names>A</given-names></name><name><surname>Green</surname><given-names>T</given-names></name><name><surname>Tunyasuvunakool</surname><given-names>K</given-names></name><name><surname>Petersen</surname><given-names>S</given-names></name><name><surname>Jumper</surname><given-names>J</given-names></name><name><surname>Clancy</surname><given-names>E</given-names></name><name><surname>Green</surname><given-names>R</given-names></name><name><surname>Vora</surname><given-names>A</given-names></name><name><surname>Lutfi</surname><given-names>M</given-names></name><name><surname>Figurnov</surname><given-names>M</given-names></name><name><surname>Cowie</surname><given-names>A</given-names></name><name><surname>Hobbs</surname><given-names>N</given-names></name><name><surname>Kohli</surname><given-names>P</given-names></name><name><surname>Kleywegt</surname><given-names>G</given-names></name><name><surname>Birney</surname><given-names>E</given-names></name><name><surname>Hassabis</surname><given-names>D</given-names></name><name><surname>Velankar</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models</article-title><source>Nucleic Acids Research</source><volume>50</volume><fpage>D439</fpage><lpage>D444</lpage><pub-id pub-id-type="doi">10.1093/nar/gkab1061</pub-id><pub-id pub-id-type="pmid">34791371</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Shang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Zhong</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Pan</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Silence of TRIB3 suppresses atherosclerosis and stabilizes plaques in diabetic ApoE-/-/LDL receptor-/- mice</article-title><source>Diabetes</source><volume>61</volume><fpage>463</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.2337/db11-0518</pub-id><pub-id pub-id-type="pmid">22275087</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>K</given-names></name><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Peng</surname><given-names>L</given-names></name><name><surname>Ren</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Adiponectin protects obese rats from aggravated acute lung injury via suppression of endoplasmic reticulum stress</article-title><source>Diabetes, Metabolic Syndrome and Obesity</source><volume>13</volume><fpage>4179</fpage><lpage>4190</lpage><pub-id pub-id-type="doi">10.2147/DMSO.S278684</pub-id><pub-id pub-id-type="pmid">33192080</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wennemers</surname><given-names>M</given-names></name><name><surname>Bussink</surname><given-names>J</given-names></name><name><surname>Scheijen</surname><given-names>B</given-names></name><name><surname>Nagtegaal</surname><given-names>ID</given-names></name><name><surname>van Laarhoven</surname><given-names>HWM</given-names></name><name><surname>Raleigh</surname><given-names>JA</given-names></name><name><surname>Varia</surname><given-names>MA</given-names></name><name><surname>Heuvel</surname><given-names>J</given-names></name><name><surname>Rouschop</surname><given-names>KM</given-names></name><name><surname>Sweep</surname><given-names>F</given-names></name><name><surname>Span</surname><given-names>PN</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Tribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia response</article-title><source>Breast Cancer Research</source><volume>13</volume><elocation-id>R82</elocation-id><pub-id pub-id-type="doi">10.1186/bcr2934</pub-id><pub-id pub-id-type="pmid">21864376</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="web"><person-group person-group-type="author"><collab>WHO</collab></person-group><year iso-8601-date="2022">2022</year><article-title>Global tuberculosis report 2022</article-title><ext-link ext-link-type="uri" xlink:href="https://www.who.int/publications/i/item/9789240061729">https://www.who.int/publications/i/item/9789240061729</ext-link><date-in-citation iso-8601-date="2022-10-27">October 27, 2022</date-in-citation></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>LSH</given-names></name><name><surname>Lee</surname><given-names>SW</given-names></name><name><surname>Huang</surname><given-names>KY</given-names></name><name><surname>Lee</surname><given-names>TY</given-names></name><name><surname>Hsu</surname><given-names>PWC</given-names></name><name><surname>Weng</surname><given-names>JTY</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Systematic expression profiling analysis identifies specific microRNA-gene interactions that may differentiate between active and latent tuberculosis infection</article-title><source>BioMed Research International</source><volume>2014</volume><elocation-id>895179</elocation-id><pub-id pub-id-type="doi">10.1155/2014/895179</pub-id><pub-id pub-id-type="pmid">25276827</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xing</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>P</given-names></name><name><surname>Hu</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Zhou</surname><given-names>G</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>TRIB3 promotes lung adenocarcinoma progression via an enhanced warburg effect</article-title><source>Cancer Management and Research</source><volume>12</volume><fpage>13195</fpage><lpage>13206</lpage><pub-id pub-id-type="doi">10.2147/CMAR.S287956</pub-id><pub-id pub-id-type="pmid">33380827</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokoyama</surname><given-names>T</given-names></name><name><surname>Kanno</surname><given-names>Y</given-names></name><name><surname>Yamazaki</surname><given-names>Y</given-names></name><name><surname>Takahara</surname><given-names>T</given-names></name><name><surname>Miyata</surname><given-names>S</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Trib1 links the MEK1/ERK pathway in myeloid leukemogenesis</article-title><source>Blood</source><volume>116</volume><fpage>2768</fpage><lpage>2775</lpage><pub-id pub-id-type="doi">10.1182/blood-2009-10-246264</pub-id><pub-id pub-id-type="pmid">20610816</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>A</given-names></name><name><surname>Kato</surname><given-names>JY</given-names></name><name><surname>Nakamae</surname><given-names>I</given-names></name><name><surname>Yoneda-Kato</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>COP1 targets C/EBPα for degradation and induces acute myeloid leukemia via Trib1</article-title><source>Blood</source><volume>122</volume><fpage>1750</fpage><lpage>1760</lpage><pub-id pub-id-type="doi">10.1182/blood-2012-12-476101</pub-id><pub-id pub-id-type="pmid">23884858</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Deng</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>SJ</given-names></name><name><surname>de The</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>TX</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Sumoylation of CCAAT/enhancer-binding protein α promotes the biased primitive hematopoiesis of zebrafish</article-title><source>Blood</source><volume>117</volume><fpage>7014</fpage><lpage>7020</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-12-325712</pub-id><pub-id pub-id-type="pmid">21596856</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zahid</surname><given-names>S</given-names></name><name><surname>Basharat</surname><given-names>S</given-names></name><name><surname>Fakhar</surname><given-names>M</given-names></name><name><surname>Rashid</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Molecular dynamics and structural analysis of the binding of COP1 E3 ubiquitin ligase to β-catenin and TRIB pseudokinases</article-title><source>Proteins</source><volume>90</volume><fpage>993</fpage><lpage>1004</lpage><pub-id pub-id-type="doi">10.1002/prot.26292</pub-id><pub-id pub-id-type="pmid">34881468</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Tian</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Garvey</surname><given-names>WT</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>TRIB3 mediates glucose-induced insulin resistance via a mechanism that requires the hexosamine biosynthetic pathway</article-title><source>Diabetes</source><volume>62</volume><fpage>4192</fpage><lpage>4200</lpage><pub-id pub-id-type="doi">10.2337/db13-0312</pub-id><pub-id pub-id-type="pmid">23990361</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>Q</given-names></name><name><surname>Yang</surname><given-names>T</given-names></name><name><surname>Ding</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cellular metabolism and macrophage functional polarization</article-title><source>International Reviews of Immunology</source><volume>34</volume><fpage>82</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.3109/08830185.2014.969421</pub-id><pub-id pub-id-type="pmid">25340307</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.95980.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rothlin</surname><given-names>Carla V</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03v76x132</institution-id><institution>Yale University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>This is a valuable study that defines the role of the pseudokinase Tribbles1 in the host response to mycobacteria. The data supports the function of Tribbles in a host protective, Cop-1 dependent, inflammatory response to Mycobacterium marinum in zebrafish and is deemed solid. This study would be of interest to scientists focused on host-pathogen interactions.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.95980.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Rothlin</surname><given-names>Carla V</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03v76x132</institution-id><institution>Yale University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p>[Editors' note: this paper was reviewed by <ext-link ext-link-type="uri" xlink:href="https://www.reviewcommons.org/">Review Commons</ext-link>.]</p><p>Thank you for resubmitting your work entitled &quot;Tribbles1 is host protective during in vivo mycobacterial infection&quot; for further consideration by <italic>eLife</italic>. Your revised article has been evaluated by Carla Rothlin (Senior Editor) and a Reviewing Editor.</p><p>The manuscript has been improved but there are some remaining issues that need to be addressed, as outlined below:</p><p>Reviewer comments:</p><p>The authors have addressed some of the points I made, but some points still need to be fully addressed.</p><p>1. The main article I was meaning with regard to Trib regulation was: Rishi, L., Hannon, M., Salomè, M., Hasemann, M., Frank, A.-K., Campos, J., Timoney, J., O'Connor, C., Cahill, M. R., Porse, B., and Keeshan, K. (2014) Regulation of Trib2 by an E2F1-C/EBPα feedback loop in AML cell proliferation, Blood 123, 2389-2400.</p><p>Admittedly I refer to human when the work is both mouse and human but the authors go into some depth about TRIB2 regulation/promoter regions. It would still be nice if the authors consider parallels between transcriptional regulation of human and zebrafish Tribbles, if they are aiming to promote a model system. There are also summaries of potential transcriptional sites in the different TRIB promoters in the articles below.</p><p>-Eyers, P. A., Keeshan, K., and Kannan, N. (2017) Tribbles in the 21st Century: The Evolving Roles of Tribbles Pseudokinases in Biology and Disease, Trends Cell Biol., Elsevier Ltd 27, 284-298.</p><p>-Salomé, M., Hopcroft, L., and Keeshan, K. (2018) Inverse and correlative relationships between TRIBBLES genes indicate non-redundant functions during normal and malignant hemopoiesis, Exp. Hematol. 66, 63-78.e13.</p><p>2. While the authors have added alphafold models they are not presented in a manner that builds confidence that the overlays are performed correctly. The same orientation should be used for each of the panels E-G, and the overlays look surprisingly poor given the sequence homology. It looks to me that the authors are trying to superimpose the entire structure of TRIB2, when they should superimpose just the C-terminal domains. I would strongly suggest the authors consult a local structural biologist in making sure this is right.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.95980.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>1. General Statements</p></disp-quote><p>In this paper we report the discovery that a member of the tribbles pseudokinase family, TRIB1 is expressed in human monocytes and is upregulated after stimulation with mycobacterial antigen in a human patient challenge model, the first direct link between immune cell Tribbles expression and innate immune response to infection. We then interrogated the mechanisms of Tribbles roles in TB using a human disease relevant whole-organism in vivo zebrafish model of TB. We show that specifically TRIB1 modulation can tip the battle between host and pathogen enhancing the innate immune response and reducing bacterial burden. We then uncover the <italic>molecular mechanisms</italic> responsible for the host protective effect of TRIB1, with enhanced antimicrobial reactive nitrogen species and il-1beta, via cooperation with Cop1 E3 ubiquitin ligase. Our findings demonstrate, for the first time, TRIB1 as a host moderator of antimicrobial mechanisms, whose manipulation is of benefit to the host during mycobacterial infection and as such, a potential novel therapeutic target against TB infection.</p><p>We thank the reviewers for their positive appraisal of our work and for their helpful suggestions that will improve our manuscript. In particular we would like to highlight the reviewer’s comments on the gap/need for a new zebrafish in vivo model to understand the roles of tribbles in infection that can “be extrapolated into the human system”, and how they feel these findings will be of broad interest and “significance to cross section of the research community” attracting “interest from readers in the fields of infection, immunity, hematology and animal models” alongside “researchers studying all aspects of Tribbles pseudokinase function, especially researchers seeking models to test small molecule agonists and antagonists.”</p><disp-quote content-type="editor-comment"><p>2. Point-by-point description of the revisions</p><p>Reviewer 1</p><p>Major comments</p><p>The major weakness of the manuscript is that the authors do not evaluate C/EBP transcription factors at all. It is rather surprising as they emphasize cooperation between Trib1 and Cop1 in the main title. C/EBP family proteins are key factors of Trib1-mediated modulation of granulocytes and monocytes. Also, slbo, a <italic>Drosophila</italic> homolog of C/EBP, is a target of tribbles, indicating that the pathway is evolutionary conserved. I would request the following experiments and discussions.</p><p>1. The authors should investigate the expression of the C/EBPa protein p42 isoform and/or other C/EBP family proteins such as C/EBPb, and confirm that the p42 is degraded by Trib1 overexpression and recovered by Trib1 and Cop1 knockout. It is also important to determine both p42 and p30 isoforms are preserved in zebrafish.</p></disp-quote><p>We agree that possible C/EBP roles should be discussed in detail and we have added to a reworked Discussion section between lines 407-421.</p><p>We stand by our data that the host protective mechanism of Trib1 acts requires Cop1, but we are not able to directly show a C/EBP mechanism within the scope of the current project due to a lack of tools/knowledge in the zebrafish on this (as outlined in our Review Commons Revision Plan). It is important to note that we have not claimed a C/EBP mechanism in our manuscript, and we think it is possibly unlikely given that monocyte and granulocyte numbers are not altered after TRIB1 manipulation (including new data outlined in comments below). There are many other candidates other than C/EBP that COP1 could be acting through. Some examples include MAPK (Niespolo et al., Front Immunol, 2020), JAK/Stat (Arndt er al., 2018), serine threonine kinases (Durzynska et al., Structure, 2017) and β-Catenin (Zahid et al., Proteins, 2022), pathways that are challenging to dissect in an in vivo setting. There is also evidence suggesting that COP1 and C/EBP have distinct binding sites on TRIB1, potentially uncoupling their activity in some biological situations (Murphy et al., Structure, 2015). We have now fully discussed this between lines 407-421.</p><p>We do not have antibodies or tools to detect p42 and p30 in zebrafish. As Tribbles1 regulation of C/EBPa appears to be post-translational (Bauer et al., J Clin Invest, 2015), this would be incredibly challenging to unpick in the zebrafish model due to lack of tools to do this.</p><p>In response to this comment, we have modified the title from “Tribbles1 and Cop1 cooperate to protect the host during in vivo mycobacterial infection” to “Tribbles1 is host protective during in vivo mycobacterial infection”. We believe our data does show that the protective effect of Tribbles requires Cop1, but changing the title in this way removes any suggestion that they directly cooperate in a potential C/EBP dependent manner, suggested by the reviewer. We have also further addressed this experimentally in the following reviewer comment, below.</p><disp-quote content-type="editor-comment"><p>2. Although the authors found the number of neutrophils and monocytes unchanged by Trib1 overexpression nor knockdown, they did not demonstrate the differentiation status of both cell types. This is quite an important issue, given that Trib1 knockout promotes granulocytic differentiation via C/EBPa accumulation in mice. Also, the analysis of granulocytic/monocytic differentiation will provide the crucial information how Trib1 protects the host from mycobacterial infection regulating hematopoietic cell functions. The authors should perform morphological analysis and examine cell surface marker expression to examine whether Trib1 and Cop1 modulates granulocytic and monocytic differentiation with and without Mm infection.</p></disp-quote><p>Unfortunately, we do not have the same level of immunology knowledge nor the antibodies to look at cell surface markers in zebrafish larvae (it is noted that the reviewer identifies that they “not have sufficient expertise in zebrafish models.” We agree with the reviewer that this would be an obvious and informative experiment to do in mouse models, but is not currently possible in zebrafish larval models). The transgenic promoters used (mpx for neutrophils and mpeg1 for macrophages) are robust and widely published to look at total neutrophil and macrophage numbers (Renshaw et al., Blood 2006; Ellett et al., Blood 2011). Mpx, encoding myeloperoxidase, is expressed late in neutrophil differentiation.</p><p>In response to this comment, we have performed new experiments in a number of areas:</p><p>1. We have generated a new stable Tribbles 1CRISPR-Cas9 knockout mutant and assessed neutrophil differentiation using Sudan Black (SD). SD stains neutrophil granules, the development of which is during a late phase of neutrophil differentiation. In new Figure 4—figure supplement 3F-G we show that in the stable <italic>trib1-/-</italic> mutant there is no difference in the neutrophil number at 2dpf.</p><p>2. We have investigated modulation of tribbles at the later timepoint of 3dpf to add to our 2dpf data, and show that no difference in the number of <italic>mpx:GFP</italic> neutrophils after either <italic>trib1</italic> overexpression (new Figure 5E) or <italic>trib1</italic> knockdown (new Figure 5F) at this later timepoint when alterations in myelopoiesis would be more obvious if present.</p><p>3. Interestingly, it has been shown that a zebrafish myeloid expressed C/EBP, c/ebp1, is not required for initial macrophage or granulocyte development, but its knockdown did result in reduced expression of the secondary granule gene LysC, shown by in situ hybridisation (Su et al., Zebrafish, 2007). To test this further we used an <italic>LysC:mCherry</italic> transgenic line (Buchan et al., PLoS One 2019) to assess expression in neutrophils after <italic>trib1</italic> manipulation and found no difference in the number of cells expressing LysC after either <italic>trib1</italic> overexpression (new Figure 5G) or <italic>trib1</italic> knockdown (new Figure 5H) at either 2 or 3dpf. This is consistent with <italic>trib1</italic> not acting via c/ebp1 in our models, at least at these stages of development.</p><p>We cannot perform accurate leukocyte counts during Mm infection reliably as neutrophils/macrophages cluster around infected areas and undergo cell death processes making counting challenging.</p><p>C/EBPa is found in zebrafish and is involved in myeloid differentiation and haematopoeisis (Yuan et al., Blood 2011). The most involved C/EBP in zebrafish myelopoiesis is a zebrafish specific isoform called c/ebp1 that is myeloid expressed (Lyons et al., Blood 2001). This has a highly conserved carboxy-yterminal bZIP domain but the amino-terminal domains are unique. A new manuscript has demonstrated that c/ebp1 controls eosinophilopoiesis in zebrafish (Li et al., Nature Communications, 2024 https://www.nature.com/articles/s41467-024-45029-0), and also neutrophil development, but that this only occurs from 5dpf onwards, therefore outside of the time window we are investigating in our study. This study, alongside the additional data we have collected, suggests that <italic>trib1</italic> is not acting via c/ebp1 to affect neutrophil differentiation at the timepoints investigated in our study. We have added these observations in the Results section and in the reworked discussion.</p><disp-quote content-type="editor-comment"><p>3. It is interesting that Cop1 knockdown zebrafish is viable, given its ubiquitous expression and multiple important targets of protein degradation. The authors should provide the details of phenotype of Cop1 KO larva and discuss on this issue.</p></disp-quote><p>Zebrafish mutants are much less prone to embryonic lethality compared to mice as maternally contributed protein stores allow for basic metabolic functions to occur throughout the short period of embryonic development and their development is completely external without the need for a placenta and associated gene expression (Rossant and Hopkins. Genes and Development 1992). However, in the case of the <italic>cop1</italic> CRISPant, this is a knockdown rather than a knockout, so there may be sufficient remaining Cop1 availability for development if it is indeed a requirement for larval viability. Although Cop1 knockout mice are non-viable, hypomorphs (similar to our knockdown zebrafish) are viable and develop relatively normally but are tumour prone as Cop1 is required for effective tumour suppression (Milgliorini et al., JCI, 2011).</p><p>We had not commented on the Cop1 larvae phenotype as they look like they develop normally eg. normal body axis, development. We now briefly comment on this in the Results section on line 306. Furthermore, we have now added wholebody neutrophil counts into new Figure 8—figure supplement 1C and show there is no change with <italic>cop1</italic> knockdown, suggesting no difference in granulopoiesis/neutrophil development.</p><disp-quote content-type="editor-comment"><p>4. [Optional] The effect of enhanced ERK phosphorylation by Trib1 for the protective effect against mycobacterial infection is another interesting point. It would be better if the authors could provide the ERK phosphorylation status upon Trib1 overexpression.</p></disp-quote><p>Unfortunately, we have no method to answer this question conclusively within the scope of this project (as outlined in our Review Commons Revision Plan). There are limited reports of phosphorylated ERK antibodies that work in wholemount zebrafish (eg, Maurer and Sagerström, BMC Developmental Biology, 2018, that use a rabbit antibody), but this is widely expressed in many tissues of the zebrafish and immune cells would be challenging to resolve.</p><disp-quote content-type="editor-comment"><p>5. [Optional] To obtain the more solid evidence for the Cop1 dependent function of Trib1 on mycobacteria infection, it is better to use the Trib1 mutant that loses the Cop1 binding activity. This experiment will strength the authors' conclusion of the Trib1 and Cop1 cooperation.</p></disp-quote><p>We have addressed this comment by generating a new stable zebrafish CRISPR-Cas9 Tribbles 1 knockout line with a 14 base pair deletion that is predicted to lead a premature stop at 94aa in the middle of the pseudokinase domain, lacking the catalytic loop (new Figure 4—figure supplement 3 A-D). The predicted truncated protein lacks the predicted COP1 binding area at the C terminal of the protein. We found that the stable mutant also leads to an increase in bacterial burden compared to wildtype sibling controls (new Figure 4E). As discussed above, we use Sudan Black staining in the stable mutant to demonstrate no change in neutrophil numbers (new Figure 4—figure supplement 3F-G).</p><disp-quote content-type="editor-comment"><p>Reviewer #2</p><p>The paper by Hammond et al. characterises the role of Tribbles proteins in Zebrafish in response to MTb infection. They show interesting upregulation of TRIB1 and 2, relative to TRIB3 which is not upregulated. This may provide an interesting system to further explore the role of Tribbles in response to infection, which is currently underexplored, but could do with some additional detail to stake that claim more strongly.</p><p>Major Comments</p><p>Some discussion of the mechanisms regulating TRIB1/2/3 transcriptionally is probably relevant given the differential upregulation observed during infection. There is quite a bit of characterisation of different Tribble promoter regions in humans-how does this translate to Zebrafish?</p></disp-quote><p>We are not sure exactly which studies characterising tribbles promotors the reviewer was referring to here. In response to this comment we interrogated a variable number tandem repeat identified in human tribbles 3 (Örd et al., 2020) and searched for this in the first 50,000 base pairs of the zebrafish <italic>tribbles 3</italic> promotor but did not identify this mammalian-conserved sequence. We added this detail in the Results section on lines 160-165. Further specific sequence details on other promotor region characterisation of Tribbles in the literature was not obvious to us for us to perform further searches.</p><disp-quote content-type="editor-comment"><p>Structural comparisons are relatively descriptive of identity etc. Nowadays it should be relatively straightforward to comment on structural conservation based on Alphafold models. Specific details may not be accurate but gross folds will be, and comparing those may be more informative.</p></disp-quote><p>We thank the reviewer for this suggestion as it has added useful information to our manuscript. We have now added overlays of Alphafold predictions of zebrafish Trib1, 2 and 3, with human TRIB 1, 2 and 3 in new Figure 2E-G. Gross folds and α chains are conserved between tribbles 1 and 3 zebrafish and human predications. Tribbles 2 orthologues did not overlay well, but this is most likely due to the shorter nature of the zebrafish Trib2 amino acid sequence (343 in human compared to 207 in zebrafish).</p><disp-quote content-type="editor-comment"><p>In terms of Crispr use-can it be confirmed that Crispr modified cell lines have effects at the protein level? This is not my specific expertise, but the supplementary evidence shown seems to show some genomic editing is occurring, but not necessairly how it effects protein levels.</p></disp-quote><p>We do not have antibodies that work on zebrafish Tribbles proteins to assess this directly at the protein level. However, we have now addressed this comment by generating a new stable zebrafish CRISPR Tribbles 1 knockout line to support our knockdown studies, with a 14 base pair deletion that is predicted to lead a premature stop at 94aa in the middle of the pseudokinase domain, lacking the catalytic loop (new Figure 4—figure supplement 3 A-D). Unlike the “CRISPant” knockdown work in the peer-reviewed version, this represents a stable knockout of Tribbles 1. We show in new Figure 4E that this full knockout has a similar effect on bacterial burden to the knockdown corroborating our findings in the CRISPant knockdown.</p><disp-quote content-type="editor-comment"><p>While the protective effect is stated as an effect size 'close to that of HIF-1a', is there additional rationale suggesting that the two may be linked?</p></disp-quote><p>Yes, there have been a number of studies that link Tribbles and Hif1-α. The best characterised link is in different cancer cells where Tribbles 3 has been linked to HIF-1alpha or hypoxia in breast cancer (Wennemers, Breast Cancer Research 2011), renal cell carcinoma cells (Hong et al., Inj J Biol Sci, 2019) and adenocarcinoma (Xing et al., Cancer Management Research, 2020). In <italic>Drosophila</italic> Hif-1alpha induces TRIB in fat body tissue (Noguchi et al., Genes Cells 2022). We have now added references to these studies to the relevant section in the results (lines 287-290).</p><disp-quote content-type="editor-comment"><p>Reviewer #3</p><p>Summary:</p><p>In this manuscript, the authors test the role of Tribbles psuedokinase 1 in the primary immune defence against Mycobacterium tuberculosis, the pathogen in tuberculosis. After showing increased Trib1 and 2 in response to mycobacterial infection cell culture and from biopsies of challenged human tissue, they turn to a zebrafish model of infection of the caudal vein with Mycobacterium marinum, a natural fish pathogen similar in effects on macrophages to M. tuberculosis in humans.</p><p>Authors find that overexpression of tribs 1, 2 and 3 had no strong effect on development but reduced the bacterial burder significantly for Trib1, less so for Trib2 and not at all for Trib3. Conversely, Trib1 Crisper-mediated knockdown increased Mm burde, which 3 had no effect ( and 2 guide RNAs were not effective at reducing Trib2).</p><p>Trib1 increased levels of pro-inflammatory interleukin 1 β, as measure by a reporter gne , which Trib3 had no similar effect, which was on par to the effect of the Hif-1alpha transcription factor, known to regulate il-1beta. The effect of Trib1 was not upon increased Hif-a (hence independent) but was dependent on the co-factor COP1, a known target of the Trib1 C-tail when activated</p><p>No major problems seen</p></disp-quote><p>[Editors’ note: what follows is the authors’ response to the second round of review.]</p><disp-quote content-type="editor-comment"><p>The manuscript has been improved but there are some remaining issues that need to be addressed, as outlined below:</p><p>Reviewer comments:</p><p>The authors have addressed some of the points I made, but some points still need to be fully addressed.</p><p>1. The main article I was meaning with regard to Trib regulation was: Rishi, L., Hannon, M., Salomè, M., Hasemann, M., Frank, A.-K., Campos, J., Timoney, J., O'Connor, C., Cahill, M. R., Porse, B., and Keeshan, K. (2014) Regulation of Trib2 by an E2F1-C/EBPα feedback loop in AML cell proliferation, Blood 123, 2389-2400.</p><p>Admittedly I refer to human when the work is both mouse and human but the authors go into some depth about TRIB2 regulation/promoter regions. It would still be nice if the authors consider parallels between transcriptional regulation of human and zebrafish Tribbles, if they are aiming to promote a model system. There are also summaries of potential transcriptional sites in the different TRIB promoters in the articles below.</p><p>-Eyers, P. A., Keeshan, K., and Kannan, N. (2017) Tribbles in the 21st Century: The Evolving Roles of Tribbles Pseudokinases in Biology and Disease, Trends Cell Biol., Elsevier Ltd 27, 284-298.</p><p>-Salomé, M., Hopcroft, L., and Keeshan, K. (2018) Inverse and correlative relationships between TRIBBLES genes indicate non-redundant functions during normal and malignant hemopoiesis, Exp. Hematol. 66, 63-78.e13.</p></disp-quote><p>We think this is an interesting topic, but we believe that to produce any meaningful insights on this is out of the scope of this manuscript as not enough is known about transcriptional regulation in zebrafish to directly compare it to human and mouse. We searched for any data (eg ChIP-seq) in the literature for zebrafish on the E2F and C/EBP binding sites focussed on in Rishi et al., Blood 2014 in zebrafish tribbles promoters and were unable to find any data. We also aimed to recapitulate the analysis of the human TRIB2 promoter outlined in Eyers et al., Trends Cell Biol 2017, to find putative transcriptional sites in the zebrafish <italic>trib</italic> promoters, but hit a number of stumbling blocks. The Transcription Element Search System (TESS) software used in Eyers et al., 2017 is no longer available and so we turned to other software. When searching for zebrafish transcriptional binding sites using PROMO software (https://alggen.lsi.upc.es/cgi-bin/promo_v3/; Martinez et al., Bioinformatics, 2002) we found no sites in 5kb of the promotors of zebrafish tribbles genes. We believe this to be because of the paucity of known transcriptional binding consensus sequences in the zebrafish. Indeed it was a similar story in JASPAR2024 (Rauluseviciuite et al., Nucleic Acids Research, 2024) where there are no zebrafish transcriptional binding sites in their “core” nor “invalidated” profiles databases. We also tried TFBind (Tsunoda and Takagi, Bioinformatics 1999) and Tfsitescan (http://www.ifti.org/cgi-bin/ifti/Tfsitescan.pl), which again do not have zebrafish consensus binding sites.</p><p>As none of our major findings are on TRIB2 (where the main data for the transcription site analysis exists in human/mice) we do not believe this to impact on our findings or conclusions and do not want to speculate in this area when so little is known in the zebrafish model.</p><disp-quote content-type="editor-comment"><p>2. While the authors have added alphafold models they are not presented in a manner that builds confidence that the overlays are performed correctly. The same orientation should be used for each of the panels E-G, and the overlays look surprisingly poor given the sequence homology. It looks to me that the authors are trying to superimpose the entire structure of TRIB2, when they should superimpose just the C-terminal domains. I would strongly suggest the authors consult a local structural biologist in making sure this is right.</p></disp-quote><p>Apologies, we have made an error here, thank you for spotting this. We did consult a structural biologist (as correctly inferred, this is not our area of expertise) and on their advice we used the widely-published ChimeraX, open source software to make the overlays. However, I am embarrassed to admit, we had missed an important step in the overlay process and, after further consultation, have now corrected this error in the newly revised Figure 2 (which also corrects for the overlay of TRIB2 only overlaying the domains which are present in both zebrafish and human). We have also changed the orientation of the overlays in the figures to the orientation that is standard in the literature with the N-lobe at the top and the C-lobe at the bottom (eg, McMillan et al., Cancers 2021; Murphy et al., Structure 2015; Eyers et al., Trends in Cell Biology 2017). Please note that we have provided the.cxs files in the source data for readers to observe the overlays in 3D using freely available software, so these overlays are available to readers in all orientations.</p></body></sub-article></article>